ABT News Abbott Laboratories 47.40 $ABT AAC Hol
Post# of 102241
Posted On: 02/25/2015 10:57:57 PM
ABT News Abbott Laboratories 47.40 $ABT
AAC Holdings beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 3:31PM CST
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Expands De Novo Pipeline with Hospital Entry in Southern California
Business Wire - Tue Feb 03, 5:45AM CST
AAC Holdings, Inc. (NYSE: AAC), added to its pipeline of de novo growth opportunities with the entry into a definitive agreement for the acquisition, through its subsidiary, Behavioral Healthcare Realty, LLC, of an 84-licensed-bed hospital in Aliso Viejo, California for an aggregate of $13.5 million in cash. The closing is expected to occur during the first quarter of 2015 and is subject to certain closing conditions, including the amendment or removal of certain use restrictions on the property.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Schedules Fourth Quarter 2014 Earnings Release and Conference Call Dates
Business Wire - Mon Jan 26, 3:19PM CST
AAC Holdings, Inc. (NYSE: AAC) announced details for the release of its results for the fourth quarter and year ended December 31, 2014.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Takes Next Step to Expand Outpatient Treatment Strategy with Execution of Definitive Acquisition Agreement in Rhode Island
Business Wire - Mon Jan 26, 5:45AM CST
AAC Holdings, Inc. (NYSE: AAC), through its subsidiary AAC Rhode Island Acquisition Sub, LLC, has signed a definitive agreement to acquire Clinical Services of Rhode Island, Inc. ("CSRI"
, a provider of intensive outpatient substance abuse treatment services, for $665,000 in cash and $1,335,000 worth of restricted shares of AAC Holdings' common stock. The acquisition, which is subject to certain closing conditions such as the assignment of certain contracts and the receipt of certain licenses necessary to operate the business, is expected to close during the second quarter of 2015.
AAC: 37.33 (+4.07)
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
BOFI: 89.96 (-0.66), BGMD: 0.70 (-0.08), AUO: 5.34 (+0.07), AAC: 37.33 (+4.07), AAPL: 128.79 (-3.38)
AAC Holdings, Inc. Provides Facility Updates in California, Florida and Nevada
Business Wire - Tue Jan 20, 5:45AM CST
AAC Holdings, Inc. (NYSE: AAC), disclosed that on January 8, 2015, its new substance abuse outpatient center in Las Vegas, Nevada, received full licensure for intensive outpatient treatment services and has begun treating patients at the facility.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Plans for Growth with Lease Signing for New Headquarters
Business Wire - Mon Jan 12, 2:16PM CST
AAC Holdings, Inc. (NYSE: AAC), announced plans to support its next stage of growth with the signing by its wholly owned subsidiary American Addiction Centers, Inc. of a 102,000-square-foot, 10-year lease at 200 Powell Place in Brentwood, Tennessee for its new corporate headquarters and call center. The Company expects to begin transitioning from its current space in the third quarter of 2015 with a completed move anticipated by late third quarter 2015.
AAC: 37.33 (+4.07)
Quest Diagnostics Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 12:40PM CST
Last month, Quest Diagnostics' (DGX) Simplexa Flu A/B & RSV Direct Kit won U.S. Food & Drug Administration (FDA) clearance for testing eight additional influenza viruses.
PMC: 24.25 (+0.32), AFAM: 31.15 (+1.56), AAC: 37.33 (+4.07), DGX: 71.29 (+0.67)
AAC Holdings, Inc. Executes Growth Strategy with Agreement to Acquire In-Network Substance Abuse Treatment Provider in Florida for $13 Million
Business Wire - Mon Dec 15, 3:01PM CST
American Addiction Centers, Inc., a subsidiary of AAC Holdings, Inc. (NYSE: AAC), has signed a definitive agreement to acquire Recovery First, Inc., a Florida-based provider of substance abuse treatment and rehabilitation services, for $13 million in cash. The acquisition, which is subject to certain closing conditions such as the assignment of certain contracts and the receipt of certain licenses necessary to operate the business, is expected to close during the first quarter of 2015.
AAC: 37.33 (+4.07)
Is AAC Holdings (AAC) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 7:42AM CST
One stock that might be an intriguing choice for investors right now is AAC Holdings as this security in the Specialized Health Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
AAC: 37.33 (+4.07)
Surging Earnings Estimates Signal Good News for AAC Holdings (AAC) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:31AM CST
AAC Holdings (AAC) sees solid earnings estimate revisions, and the stock is showing decent short-term momentum as well, rising nearly 45% in the past month.
AAC: 37.33 (+4.07)
AAC Holdings EPS of $0.14
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:55PM CST
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Reports Third Quarter 2014 Results
Business Wire - Wed Nov 05, 4:18PM CST
AAC Holdings, Inc. (NYSE: AAC), the parent holding company of American Addiction Centers, Inc., announced its results for the third quarter ended September 30, 2014. All comparisons included in this release are for the third quarter of 2014 to the third quarter of 2013 unless otherwise noted.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call Dates
Business Wire - Tue Oct 28, 9:21AM CDT
AAC Holdings, Inc. (NYSE: AAC), the parent holding company of American Addiction Centers, Inc., announced details for the release of its results for the third quarter ended September 30, 2014.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Announces Closing of Initial Public Offering
Business Wire - Tue Oct 07, 3:01PM CDT
AAC Holdings, Inc. (NYSE: AAC) (the "Company" , the parent holding company of American Addiction Centers, Inc., announced today the closing of its initial public offering of 5,750,000 shares of its common stock at a public offering price of $15.00 per share, which includes the exercise in full of the underwriters' over-allotment option to purchase an additional 250,000 shares from the Company and 500,000 shares from certain selling stockholders. The Company estimates net proceeds from the offering to be approximately $69.1 million after deducting underwriting discounts and commissions and estimated offering expenses.
AAC: 37.33 (+4.07)
Online Retailer Wayfair Leads List Of 6 IPOs Thursday
at Investor's Business Daily - Thu Oct 02, 3:02PM CDT
Online retailer Wayfair popped 32% in its stock market debut Thursday, leading a list of six IPOs. Wayfair (W) raised $319 million by offering 11 million shares at 29, above its expected range of 25 to 28. The stock was above 38 in late-afternoon...
ATTO: 12.01 (+0.25), W: 23.67 (-0.45), FMSA: 6.60 (-0.01), VWR: 25.67 (-0.28), AAC: 37.33 (+4.07), CALA: 16.03 (+0.31), YDLE: 12.82 (-0.19), JPEP: 14.94 (-0.12)
AAC Holdings, Inc. Announces Pricing of Initial Public Offering
Business Wire - Wed Oct 01, 6:04PM CDT
AAC Holdings, Inc. (NYSE: AAC) (the "Company" , the parent holding company of American Addiction Centers, Inc., announced today the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $15.00 per share, for a total of approximately $65.6 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. In connection with the offering, the Company and certain selling stockholders have granted the underwriters a 30-day over-allotment option to purchase up to an additional 750,000 shares of common stock. The shares are expected to begin trading tomorrow, October 2, 2014, on the New York Stock Exchange under the symbol "AAC." The offering is expected to close on October 7, 2014.
AAC: 37.33 (+4.07)
Solar Power, Biotechs Among 11 IPOs Planned This Week
at Investor's Business Daily - Mon Sep 29, 6:24PM CDT
The IPO market is maintaining a brisk pace with 11 scheduled this week, including a solar power company, three tech firms and three biotech companies. Vivint Solar (VSLR), a competitor to the Elon Musk-backed SolarCity (SCTY), plans to raise $350...
ATTO: 12.01 (+0.25), VWR: 25.67 (-0.28), JMEI: 13.30 (+0.07), ZEN: 24.42 (+0.30), VSLR: 8.08 (+0.02), JPEP: 14.94 (-0.12), W: 23.67 (-0.45), FMSA: 6.60 (-0.01), SCTY: 52.28 (-0.76), DERM: 16.91 (+0.68), AAC: 37.33 (+4.07), CALA: 16.03 (+0.31), AAVL: 36.96 (+0.27), YDLE: 12.82 (-0.19), JD: 27.30 (-0.19), BABA: 86.19 (+1.50)
Applied Optoelectronics' (AAOI) CEO Thompson Lin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - 36 mins ago
AAOI: 10.51 (+0.16)
Applied Optoelectronics posts 4Q profit
Automated Insights - Wed Feb 25, 5:24PM CST
SUGAR LAND, Texas (AP) _ Applied Optoelectronics Inc. (AAOI) on Wednesday reported fourth-quarter net income of $702,000, after reporting a loss in the same period a year earlier.
AAOI: 10.51 (+0.16)
Applied Optoelectronics beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 3:19PM CST
AAOI: 10.51 (+0.16)
Applied Optoelectronics to Announce Fourth Quarter and Year 2014 Financial Results on February 25, 2015
GlobeNewswire - Mon Jan 26, 3:03PM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced that it will release financial results for its fourth quarter and year ended December 31, 2014 after U.S. markets close on Wednesday, February 25, 2015.
AAOI: 10.51 (+0.16)
Applied Optoelectronics Reports Preliminary Fourth Quarter 2014 Revenue
GlobeNewswire - Tue Jan 13, 3:03PM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced preliminary revenue for the fourth quarter ended December 31, 2014.
AAOI: 10.51 (+0.16)
Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
ARCX: 19.48 (-0.28), AAOI: 10.51 (+0.16), BEAV: 63.72 (-0.49), BBRG: 13.68 (+0.33), BCOR: 14.27 (+0.21)
Applied Optoelectronics Completes Taiwan Factory Move
GlobeNewswire - Tue Dec 02, 7:30AM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced the completion of the move to a new, larger factory in New Taipei City, Taiwan.
AAOI: 10.51 (+0.16)
Applied Optoelectronics, Inc. Ranked Number 374 Among the Fastest Growing Companies in North America on Deloitte's 2014 Technology Fast 500(TM)
GlobeNewswire - Thu Nov 13, 10:58AM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI) today announced it ranked No. 374 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. The ranking was based on Applied Optoelectronics' 214% revenue growth from 2009 to 2013.
AAOI: 10.51 (+0.16)
Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST
FSM: 4.39 (+0.10), HEAR: 2.57 (+0.02), JRJC: 5.85 (+0.23), CVO: 2.14 (+0.24), AAOI: 10.51 (+0.16), UNIS: 4.09 (+0.12), HIIQ: 7.13 (-0.03), CYAN: 8.16 (-0.02), PTX: 10.34 (+0.79), TRMR: 2.43 (+0.01), PRKR: 0.98 (-0.05), SUMR: 2.78 (-0.07), VSLR: 8.08 (+0.02), RVP: 4.22 (+0.01), ASCMA: 44.86 (+0.31), ICUI: 88.15 (-0.18), CALL: 7.49 (-0.14), DMD: 4.96 (+0.04), AST: 3.94 (-0.02), ASEI: 52.10 (-0.54)
Applied Optoelectronics (AAOI) Stock Lower After Earnings Miss
at The Street - Tue Nov 11, 9:55AM CST
Applied Optoelectronics (AAOI) is falling Tuesday after missing analysts' estimates for earnings in the third quarter
AAOI: 10.51 (+0.16)
Applied Optoelectronics misses by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:37PM CST
AAOI: 10.51 (+0.16)
Applied Optoelectronics Reports Sixth Consecutive Quarter of Record Revenue
GlobeNewswire - Mon Nov 10, 3:10PM CST
Third Quarter 2014 Highlights
AAOI: 10.51 (+0.16)
Infinera Stock Pops After Q3 Beat, Raised Outlook
at Investor's Business Daily - Thu Oct 23, 11:25AM CDT
Infinera stock soared to a more than six-year high Thursday after the fiber-optics parts maker posted Q3 earnings late Wednesday that blew past estimates and raised its Q4 guidance. Sunnyvale, Calif.-based Infinera (INFN) saw its stock rise 25% in...
FNSR: 20.79 (-0.05), AAOI: 10.51 (+0.16), JDSU: 13.39 (-0.12), CIEN: 20.79 (+0.40), INFN: 17.33 (-0.05)
iRobot Beats on Q3 Earnings, Hikes 2014 EPS Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 1:30PM CDT
iRobot Corporation (IRBT) reported strong earnings and improved year over year revenues for the third quarter of 2014.
AAOI: 10.51 (+0.16), AA: 15.00 (-0.74), IRBT: 32.39 (+0.35), AAPL: 128.79 (-3.38)
The Zacks Analyst Blog Highlights:iRobot, Alcoa, Applied Optoelectronics and Apple
PR Newswire - Wed Oct 22, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iRobot Corporation (Nasdaq:IRBT-Free Report), Alcoa Inc. (NYSE:AA-Free Report), Applied Optoelectronics, Inc. (Nasdaq:AAOI-Free Report) and Apple Inc. (Nasdaq:AAPL-Free Report).
AAOI: 10.51 (+0.16), AA: 15.00 (-0.74)
iRobot to Ride Growth Trajectory on New Contracts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:52PM CDT
Premier robot manufacturing company iRobot Corporation (IRBT) announced the receipt of a new contract from the Naval Surface Warfare Center, Indian Head Explosive Ordnance Disposal Technology Division.
AAOI: 10.51 (+0.16), AA: 15.00 (-0.74), IRBT: 32.39 (+0.35), AAPL: 128.79 (-3.38)
Applied Optoelectronics, Inc. (AAOI) in Focus: Stock Soars 10.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:18AM CDT
Applied Optoelectronics, Inc. (AAOI) was a big mover last session, as the company saw its shares rise by above 10% on the day.
AMKR: 9.24 (-0.18), AMBA: 56.64 (-1.06), AAOI: 10.51 (+0.16), RMBS: 12.07 (-0.05)
Applied Optoelectronics to Announce Third Quarter 2014 Financial Results on November 10, 2014
GlobeNewswire - Tue Oct 07, 3:03PM CDT
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced that it will release financial results for its third quarter ended September 30, 2014 after U.S. markets close on Monday, November 10, 2014.
AAOI: 10.51 (+0.16)
These 5 Big Caps Hit New Closing Highs
at Investor's Business Daily - Wed Feb 25, 7:02AM CST
A handful of big companies made big moves Tuesday as several Apple (AAPL) chip suppliers and two pharmaceutical distributors hit new closing highs. Today's Screen of the Day features Big Cap Leaders, generally top stocks with market values of at...
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), SWKS: 87.73 (-0.45), CAH: 88.30 (-0.95), TSM: 25.04 (unch), AAPL: 128.79 (-3.38), AVGO: 112.68 (-0.50)
Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 8:30AM CST
Pharmacy benefit manager Express Scripts Holding Company posted fourth-quarter 2014 earnings per share (excluding special items) of $1.39, beating the Zacks Consensus Estimate by a penny.
ABC: 103.29 (+0.32), ESRX: 85.09 (-2.53), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95)
AmerisourceBergen completes takeover of MWI Vet Supply
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 7:33AM CST
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 5:14PM CST
Following a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel, the CMS has approved a pass-through payment for CR Bard Inc.'s (BCR) Lutonix DCB.
HYH: 46.75 (-0.76), BSX: 16.92 (+0.30), ABC: 103.29 (+0.32), BCR: 171.62 (-2.86)
LabCorp Hits New 52-Week High on Strong Q4, Covance Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 8:42AM CST
On Feb 19, 2015, LabCorp (LH) finally completed the gigantic $5.7 billion acquisition of drug development major Covance Inc.
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95), LH: 122.40 (+0.19)
LabCorp Beats Q4 Earnings, Positive on Covance Addition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 9:27AM CST
Laboratory Corporation of America Holdings (LH) reported a solid fourth-quarter 2014 with adjusted earnings per share (EPS) of $1.65, up 2.5% from the year-ago quarter.
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95), LH: 122.40 (+0.19)
AmerisourceBergen Up 51.2% Since SmarTrend Uptrend Call (ABC)
Comtex SmarTrend(R) - Thu Feb 19, 9:35AM CST
SmarTrend identified an Uptrend for AmerisourceBergen (NYSE:ABC) on May 12th, 2014 at $66.30. In approximately 9 months, AmerisourceBergen has returned 51.21% as of today's recent price of $100.25.
ABC: 103.29 (+0.32)
AmerisourceBergen prices USD1,000m senior notes
M2 - Wed Feb 18, 6:09AM CST
Pharmaceutical company AmerisourceBergen (NYSE:ABC) said on Tuesday that it has priced USD500m aggregate principal amount of its 3.25% Senior Notes due 1 March 2025 and USD500m aggregate principal amount of its 4.25% Senior Notes due 1 March 2045 (collectively, the "Notes" , in an underwritten registered public offering.
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
Vascular Solutions Set to Join the S&P SmallCap 600
PR Newswire - Tue Feb 17, 4:55PM CST
Vascular Solutions Inc. (NASD: VASC) will replace MWI Veterinary Supply Inc. (NASD: MWIV) in the S&P SmallCap 600 after the close of trading on Monday, February 23. S&P 500 constituent AmerisourceBergen Corp. (NYSE: ABC) is acquiring MWI Veterinary Supply in a transaction expected to be completed soon.
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10), VASC: 28.81 (-0.14), MHFI: 103.68 (-0.33)
AmerisourceBergen prices $1B debt offering
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 2:47PM CST
ABC: 103.29 (+0.32)
AmerisourceBergen Prices $500 Million 3.25% Senior Notes Due 2025 and $500 Million 4.25% Senior Notes Due 2045
Business Wire - Tue Feb 17, 2:37PM CST
AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 3.25% Senior Notes due March 1, 2025 and $500 million aggregate principal amount of its 4.25% Senior Notes due March 1, 2045 (collectively, the "Notes" , in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC" on November 27, 2012. The offering is expected to close on February 20, 2015, subject to customary closing conditions. AmerisourceBergen intends to use the net proceeds from the offering, together with the net proceeds from the recently announced $1 billion senior unsecured term loan credit facility and cash on hand, to finance the previously disclosed proposed acquisition (the "Acquisition" of MWI Veterinary Supply, Inc. ("MWI" , and to pay related fees and expenses, including the retirement of all outstanding indebtedness of MWI. The offering is not contingent on the consummation of the Acquisition which, if completed, will occur subsequent to the closing of the offering. In the event that the Acquisition is not completed on or before May 15, 2015, or, if prior to such time, the acquisition agreement is terminated, other than in connection with the consummation of the Acquisition, and is not otherwise amended or replaced, then the Notes are subject to mandatory redemption, in whole but not in part, at a redemption price equal to 101% of the aggregate principal amount of the Notes, plus accrued and unpaid interest to, but not including, the redemption date. The Notes offering is expected to close prior to the consummation of the Acquisition.
ABC: 103.29 (+0.32), WFC: 55.33 (-0.04)
Fitch Affirms AmerisourceBergen's Ratings at 'A-'; Outlook Negative
Business Wire - Tue Feb 17, 1:24PM CST
Fitch Ratings has affirmed the ratings for AmerisourceBergen Corp. (NYSE: ABC), including the Long-term Issuer Default Rating (IDR) at 'A-'. The ratings have been removed form Negative Watch. The Rating Outlook is Negative.
ABC: 103.29 (+0.32)
MWI Veterinary: Benefits of Takeover by AmerisourceBergen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 3:58PM CST
On Feb 11, 2015, we issued an updated research report on MWI Veterinary Supply Inc. (MWIV).
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10), CAH: 88.30 (-0.95), LH: 122.40 (+0.19)
Uptrend Call Working As AmerisourceBergen Stock Rises 48.6% (ABC)
Comtex SmarTrend(R) - Thu Feb 12, 9:11AM CST
SmarTrend identified an Uptrend for AmerisourceBergen (NYSE:ABC) on May 12th, 2014 at $66.29. In approximately 9 months, AmerisourceBergen has returned 48.59% as of today's recent price of $98.51.
ABC: 103.29 (+0.32)
Henry Schein (HSIC) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:48AM CST
We are impressed with Henry Schein's (HSIC) fourth-quarter 2014 financial results which modestly beat the Zacks Consensus Estimate for EPS, while being in line with the same for revenues.
HYH: 46.75 (-0.76), ABC: 103.29 (+0.32), BRLI: 35.05 (+0.47), HSIC: 141.01 (-0.38)
AmerisourceBergen's World Courier Expands Global Presence with New Distribution Facility in Melbourne, Australia
PR Newswire - Wed Feb 11, 1:00PM CST
World Courier, the global leader in specialty logistics and an AmerisourceBergen company, has opened the doors to its new distribution facility in Melbourne, Australia. This is the first facility in AmerisourceBergen's global network to be purpose-built to support clinical trial logistics and commercial third-party logistics (3PL). In conjunction with World Courier's specialty logistics and transportation offerings, the facility provides a complete portfolio of supply chain solutions for pharmaceutical manufacturer partners.
ABC: 103.29 (+0.32)
Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:54AM CST
Charles River Laboratories (CRL) reported fourth-quarter 2014 earnings (excluding special items) of 81 cents per share, easily beating both the Zacks Consensus Estimate of 71 cents.
BIIB: 408.94 (+4.05), ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CRL: 76.80 (+0.50)
AmerisourceBergen Announces Expiration of the Hart-Scott-Rodino Waiting Period for AmerisourceBergen's Proposed Acquisition of MWI Veterinary Supply, Inc.
Business Wire - Wed Feb 11, 6:30AM CST
AmerisourceBergen Corporation (NYSE:ABC) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its tender offer to purchase all outstanding shares of MWI Veterinary Supply, Inc. (NASDAQ: MWIV) has expired.
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
Health Care Providers and Services Equities Technical Momentum -- Cardinal Health, AmerisourceBergen, Community Health Systems, Select Medical Holdings, and McKesson
PR Newswire - Tue Feb 10, 7:35AM CST
Editor Note: For more information about this release, please scroll to bottom.
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95), CYH: 47.70 (-0.28), SEM: 12.82 (+0.50)
Why In The World Would AmerisourceBergen Acquire MWI Veterinary?
Rochelle Jenks - at Seeking Alpha - Tue Feb 10, 5:45AM CST
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
ABM Industries Up 13.0% Since SmarTrend Uptrend Call (ABM)
Comtex SmarTrend(R) - Thu Feb 19, 9:32AM CST
SmarTrend identified an Uptrend for ABM Industries (NYSE:ABM) on October 29th, 2014 at $27.14. In approximately 4 months, ABM Industries has returned 12.95% as of today's recent price of $30.65.
ABM: 30.73 (-0.39)
ABM to Present at Baird's 2015 Business Solutions Conference
GlobeNewswire - Tue Feb 17, 11:23AM CST
ABM (NYSE:ABM), a leading provider of facility solutions, today announced that Scott Salmirs, executive vice president, James Lusk, executive vice president, and David Farwell, senior vice president, will be presenting at the Baird Business Solutions Conference on Tuesday, February 24, 2015. The presentation will be held at The Pierre Hotel located in New York, New York and will begin at 3:35 p.m. ET.
ABM: 30.73 (-0.39)
The Hidden Risk Of High Dividend Growth Stocks
Kurtis Hemmerling - at Seeking Alpha - Mon Feb 16, 5:08AM CST
BDX: 148.11 (-0.59), ADP: 89.07 (-0.19), ADM: 48.10 (-0.55), ATO: 53.15 (-0.18), APD: 157.05 (+0.07), ABM: 30.73 (-0.39)
Can VASCO (VDSI) Keep its Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 10:00AM CST
VASCO Data Security International Inc. (VDSI) is set to report its fourth-quarter 2014 results before the opening bell on Feb 17.
VDSI: 25.42 (-0.87), KR: 72.35 (-0.57), ABM: 30.73 (-0.39), TV: 33.60 (-0.22)
ABM to Reduce West Boylston, MA Energy and Operating Costs by More Than $4.1 Million
GlobeNewswire - Thu Feb 12, 6:07PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, announces that this month its ABM Building Solutions business will complete a multi-million dollar contract of extensive energy and facility improvements to government and school buildings throughout the Town of West Boylston in Massachusetts. ABM's Bundled Energy Solutions program guarantees that the project will save the Town of West Boylston at least $4.1 million in energy and operating costs over the next 15 years.
ABM: 30.73 (-0.39)
ABM Awarded Integrated Facility Solutions Contract by Harley-Davidson
GlobeNewswire - Tue Feb 10, 4:00PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, has been awarded a multi-phased, integrated facility solutions contract by Harley-Davidson Motor Company.
ABM: 30.73 (-0.39)
5 Reasons To Take A Look At Telkonet
Joe Springer - Seeking Alpha - Mon Feb 02, 4:19PM CST
Telkonet (OTCQB: TKOI ) is an intelligent automation company that provides networked services for large commercial and residential buildings and facilities. Its services provide energy and operational savings as well as added value for its customers....
HON: 104.39 (+0.09), ENOC: 18.88 (+0.88), NMRX: 11.14 (-0.20), JCI: 51.34 (+0.55), CTRL: 12.75 (-0.26), ABM: 30.73 (-0.39)
Can Vulcan Materials (VMC) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 1:10PM CST
Vulcan Materials Company (VMC) is set to report fourth-quarter fiscal 2014 results on Feb 5, before the market opens.
TPH: 15.91 (+0.04), VMC: 82.38 (+1.65), SERV: 32.88 (+0.63), ABM: 30.73 (-0.39)
Can Jacobs (JEC) Deliver Yet Another Earnings Beat in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 4:05PM CST
Jacobs Engineering Group Inc. (JEC) is scheduled to report first-quarter fiscal 2015 results after the opening bell on Jan 28, 2015.
JEC: 44.75 (+0.24), GPN: 92.13 (+0.21), WNS: 23.87 (+0.58), ABM: 30.73 (-0.39)
Is ABM Industries (ABM) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 7:52AM CST
ABM Industries in the Building-Maintenance and Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
ABM: 30.73 (-0.39)
ABM Industries Appoints New Chief Executive Officer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 9:40AM CST
ABM Industries Incorporated (ABM), recently announced the appointment of Scott Salmirs as its Chief Executive Officer (CEO).
CBZ: 9.02 (+0.10), SERV: 32.88 (+0.63), ROL: 33.63 (-0.30), ABM: 30.73 (-0.39)
ABM appoints Scott Salmirs as CEO
M2 - Tue Jan 13, 3:59AM CST
ABM (NYSE:ABM), a provider of facility solutions, disclosed on Tuesday that its board of directors elected executive vice president (EVP) Scott Salmirs as successor to current president and chief executive officer (CEO) Henrik Slipsager, as of 31 March 2015.
ABM: 30.73 (-0.39)
ABM Names Industry Veteran Scott Salmirs as Next CEO
Business Wire - Mon Jan 12, 3:01PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, today announced that its board of directors has named executive vice president Scott Salmirs to succeed current president and chief executive officer Henrik Slipsager, effective March 31, 2015. The board and Slipsager together determined that because of the company's recent strong performance, its depth of talent, and the completion of its reorganization and re-branding, it is the appropriate time to effect a leadership transition as a part of the board's succession planning.
ABM: 30.73 (-0.39)
ABM Granted Reversal of $94 Million Class Action Verdict - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 9:10AM CST
The California Court of Appeal recently repealed a $94 million verdict related to a wage-and-hour class action against ABM Industries (ABM).
SERV: 32.88 (+0.63), IT: 84.36 (-0.41), ROL: 33.63 (-0.30), ABM: 30.73 (-0.39)
ABM Industries meets 4Q profit forecasts
Automated Insights - Mon Jan 05, 1:46PM CST
NEW YORK (AP) _ ABM Industries Inc. (ABM) on Monday reported fiscal fourth-quarter net income climbed by 74 percent to $27.9 million.
ABM: 30.73 (-0.39)
ABM Wins Unanimous Reversal of $94 Million Judgment
GlobeNewswire - Mon Jan 05, 12:02PM CST
On December 31, 2014, ABM Industries Incorporated (NYSE:ABM) obtained reversal of a $94 million judgment in a wage-and-hour class action that was awarded by a California trial court in 2012. The California Court of Appeal, Second District, rejected the plaintiffs' theory that the company violated wage-and-hour laws by requiring some employees to remain "on call" and carry radios during rest breaks. In reversing the trial court's erroneous grant of summary judgment for the plaintiffs, the Court of Appeal agreed with ABM that "on-call" rest breaks are permissible under California law.
ABM: 30.73 (-0.39)
4 Reasons To Be Bullish On ABM Industries
Diesel - at Seeking Alpha - Thu Jan 01, 3:41AM CST
ABM: 30.73 (-0.39)
ABM Industries Earnings Hindsight: Up 3.6% in Last 14 Days (ABM)
Comtex SmarTrend(R) - Mon Dec 22, 7:11AM CST
When ABM Industries (NYSE:ABM) reported earnings 14 days ago on December 8th, 2014, analysts, on average, expected the company to report earnings of $0.57 on sales of $1.3 billion. ABM Industries actually reported earnings of $0.52 per share on sales of $1.3 billion, missing EPS estimates by $0.05 and beating revenue estimates by $1.1 million. Shares of ABM Industries have climbed from $27.04 to $28.00, representing a gain of 3.6% since the company reported earnings 14 days ago.
ABM: 30.73 (-0.39)
The Best Small-Cap Dividend Growers: Heartland Payment Systems
Stan Stafford - at Seeking Alpha - Wed Dec 17, 4:22AM CST
HPY: 49.40 (-0.24), NSP: 50.68 (-0.06), GK: 72.05 (-0.64), HCSG: 33.49 (+0.28), VVI: 27.51 (+0.16), ABM: 30.73 (-0.39)
Facilities Management - Global Strategic Business Report
M2 - Tue Dec 16, 8:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/jj3hpx/facilities) has announced the addition of the "Facilities Management - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Facilities Management in US$ Billion. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 108 companies including many key and niche players such as: ABM Industries Incorporated - Amey Plc - Aramark Corporation - Bellrock Limited - Bilfinger Europa Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MARKET TRENDS AND DRIVERS 3. COMPETITION 4. SERVICE OVERVIEW 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD - A.Market Analysis - Current & Future Analysis - Focus on Select Regional Markets - Middle East - The Cleaning Industry of Saudi Arabia - Brazil and Mexico - Recent Industry Activity B.Market Analytics IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 108 (including Divisions/Subsidiaries 118) - The United States (25) - Europe (63) - France (2) - Germany (2) - The United Kingdom (54) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (23) - Middle East (7) For more information visit http://www.researchandmarkets.com/research/jj3hpx/facilities
ABM: 30.73 (-0.39)
Drugmaker Mylan Takes Part In Pharma Feeding Frenzy
at Investor's Business Daily - Mon Feb 23, 1:59PM CST
In a rapidly consolidating industry, you're either hunter or prey. Mylan is the former. Mylan (MYL) makes generic and branded drugs to treat illnesses of the cardiovascular and central nervous systems and other disorders. It operates two segments:...
BIIB: 408.94 (+4.05), ABT: 47.40 (-0.07), VRX: 198.00 (-4.00), ACT: 290.40 (+1.29), SLXP: 156.67 (-0.43), MYL: 56.50 (-0.72), TKMR: 19.43 (-0.30), BMY: 61.22 (-0.23), AGN: 232.48 (+0.60), SHPG: 245.10 (+7.48), NPSP: 45.97 (+0.01), TBPH: 21.05 (+0.60)
Pharma M&A: Bristol-Myers, Valeant Make Deals
at Investor's Business Daily - Mon Feb 23, 11:41AM CST
The drug industry's recent spate of deals got another shot in the arm Monday as Bristol-Myers Squibb announced plans to acquire a privately held drugmaker for up to $1.25 billion, a day after Valeant Pharmaceuticals International (VRX) said that it...
AGN: 232.48 (+0.60), BIIB: 408.94 (+4.05), ABT: 47.40 (-0.07), ACT: 290.40 (+1.29), VRX: 198.00 (-4.00), SHPG: 245.10 (+7.48), TKMR: 19.43 (-0.30), NPSP: 45.97 (+0.01), MYL: 56.50 (-0.72), BMY: 61.22 (-0.23)
Positive Ad Comm vote for Vertiflex Interspinous Spacer
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 10:04AM CST
JNJ: 101.21 (+0.51), ABT: 47.40 (-0.07), MDT: 78.63 (-0.39)
The Top Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Feb 23, 2:37AM CST
ELLI: 53.71 (-0.27), JCOM: 67.41 (+0.03), CAH: 88.30 (-0.95), CIEN: 20.79 (+0.40), AET: 99.52 (-0.65), ANAC: 43.57 (+0.65), CSL: 95.10 (+0.63), HSIC: 141.01 (-0.38), MNK: 116.15 (-1.67), CAVM: 67.21 (unch), HAS: 62.08 (+0.03), BCR: 171.62 (-2.86), MCHP: 51.35 (-0.18), MYL: 56.50 (-0.72), DEPO: 22.52 (-0.19), HRL: 58.53 (+0.76), CSX: 35.21 (-0.36), DYAX: 15.32 (-0.08), LVLT: 53.87 (-0.04), CBRL: 149.56 (+3.75), MTSI: 33.53 (-1.26), AZO: 637.12 (-0.67), KNX: 32.95 (-0.04), HAE: 44.14 (+0.03), FSL: 36.29 (unch), BDX: 148.11 (-0.59), ACT: 290.40 (+1.29), BLL: 72.16 (-0.40), NUVA: 45.50 (-2.96), CDW: 38.03 (-0.06), ADBE: 78.07 (+0.39), AFFX: 11.64 (+0.07), AGN: 232.48 (+0.60), ANTM: 146.97 (-0.31), APH: 56.85 (+0.03), INFA: 43.63 (+0.08), EXAM: 40.72 (+0.45), LII: 104.70 (-1.11), CNMD: 51.53 (+0.19), BJRI: 52.47 (-0.59), DLX: 68.20 (-0.77), ABT: 47.40 (-0.07), ENDP: 85.19 (-0.06), ABCO: 53.12 (-0.58), DIOD: 28.45 (-0.16), LEG: 45.21 (-0.09), DIS: 105.57 (+0.90), GLW: 24.60 (-0.18), MAR: 82.36 (+0.11), IMAX: 35.12 (+0.19), CNC: 61.65 (+0.29), IGV: 97.86 (+0.43), CTAS: 83.70 (+0.53), FLT: 156.94 (-0.02), CMCSA: 59.62 (+0.45), FLO: 21.54 (-0.19), CRM: 62.87 (+0.94)
The Passive DGI Portfolio: Portfolio Update #3
Financially Free Investor - at Seeking Alpha - Mon Feb 23, 1:38AM CST
DWX: 44.73 (+0.14), LMT: 204.86 (-1.76), CLX: 108.99 (-0.38), MDT: 78.63 (-0.39), MON: 124.23 (-0.71), UTX: 123.37 (-0.42), WMT: 83.57 (-1.00), O: 51.10 (+0.23), INTC: 33.94 (-0.47), PEP: 99.50 (-0.08), JNJ: 101.21 (+0.51), CDK: 46.99 (-0.37), QCOM: 71.68 (+0.31), MSFT: 43.99 (-0.10), APD: 157.05 (+0.07), ABT: 47.40 (-0.07), HCP: 42.30 (+0.14), EMR: 58.30 (-0.25), COP: 67.53 (+0.44), MO: 55.64 (-0.08), WM: 54.53 (+0.06), WBA: 80.01 (-0.38), ADP: 89.07 (-0.19), OHI: 40.86 (+0.80), MCD: 98.66 (+3.68), TEVA: 56.52 (-0.26), PG: 85.46 (-0.04), CVX: 108.58 (+0.62), AFL: 61.95 (-0.11), CL: 71.01 (unch)
Abbott Laboratories declares $0.24 dividend
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:42AM CST
ABT: 47.40 (-0.07)
Makers of pricey drugs working on new payment model
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:10AM CST
ABT: 47.40 (-0.07), BIIB: 408.94 (+4.05), BMRN: 107.50 (+1.47), PFE: 34.66 (+0.32), SGMO: 16.86 (+0.38), AMGN: 158.08 (+0.71), LLY: 70.36 (-0.54), BMY: 61.22 (-0.23), GSK: 47.72 (+0.02), CELG: 123.10 (-0.08), JNJ: 101.21 (+0.51), QURE: 21.65 (+1.20), GILD: 104.43 (-0.27), BAX: 68.86 (-0.20), MRK: 58.49 (+0.13), AZN: 69.67 (+0.35), NVS: 102.64 (-0.01)
Abbott to Present at Cowen and Company 35th Annual Health Care Conference
PR Newswire - Thu Feb 19, 8:00AM CST
Abbott (NYSE: ABT) will present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3, 2015. Scott White, senior vice president, international nutrition, and Brian Yoor, vice president, investor relations, will participate in the conference at 9 a.m. Central time.
ABT: 47.40 (-0.07)
The Best Large Cap Stocks To Buy In Portfolios
Todd Campbell - at Seeking Alpha - Thu Feb 19, 6:43AM CST
OCR: 75.20 (-1.47), CAH: 88.30 (-0.95), PSA: 198.28 (-0.22), SLG: 127.12 (+0.24), AET: 99.52 (-0.65), VTR: 74.43 (-0.11), HSIC: 141.01 (-0.38), HAS: 62.08 (+0.03), BCR: 171.62 (-2.86), OTEX: 58.73 (+0.50), MCHP: 51.35 (-0.18), MYL: 56.50 (-0.72), HRL: 58.53 (+0.76), NXPI: 84.89 (-1.02), CSX: 35.21 (-0.36), BA: 153.01 (-1.37), NVDA: 22.14 (-0.17), LVLT: 53.87 (-0.04), AZO: 637.12 (-0.67), AVB: 167.98 (-0.92), SIAL: 138.07 (-0.24), SPLK: 67.50 (+1.06), FSL: 36.29 (unch), ASH: 128.01 (+1.06), BDX: 148.11 (-0.59), ACT: 290.40 (+1.29), BLL: 72.16 (-0.40), AON: 100.45 (-0.14), CDW: 38.03 (-0.06), ADBE: 78.07 (+0.39), AGN: 232.48 (+0.60), ANTM: 146.97 (-0.31), APH: 56.85 (+0.03), V: 273.01 (+0.54), Q: 65.03 (+0.54), APD: 157.05 (+0.07), PII: 157.19 (+2.07), ENDP: 85.19 (-0.06), ABT: 47.40 (-0.07), HCN: 77.63 (+1.13), ORLY: 208.69 (+1.15), DIS: 105.57 (+0.90), GLW: 24.60 (-0.18), MAR: 82.36 (+0.11), CTAS: 83.70 (+0.53), PLL: 102.17 (-1.28), FLT: 156.94 (-0.02), CMCSA: 59.62 (+0.45), CRM: 62.87 (+0.94)
Ad Comm review approaches for Vertiflex spinal implant
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 12:54PM CST
JNJ: 101.21 (+0.51), ABT: 47.40 (-0.07), MDT: 78.63 (-0.39)
Accelerate Diagnostics - A Misleading Story Ripe For Decline
Shareholder Watchdog - Seeking Alpha - Wed Feb 18, 10:28AM CST
We ended our two-year hiatus from publishing on Seeking Alpha given a unique short opportunity that we think could decline by over 65%. Like our other reports, investors need to be very aware and cautious given the degree of risk we have identified....
ABT: 47.40 (-0.07), BDX: 148.11 (-0.59), AXDX: 19.03 (+0.66), TTOO: 16.82 (-0.11), NVS: 102.64 (-0.01), NSPH: 0.29 (unch)
Oral Proteins and Peptides Market, 2015 - 2025
M2 - Wed Feb 18, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/g33dxb/oral_proteins_and) has announced the addition of the "Oral Proteins and Peptides Market, 2015 - 2025" report to their offering. The Oral Proteins and Peptides Market (2nd edition), 2015-2025 report provides a comprehensive analysis of the current state of the market and the likely future evolution over the next ten years. Endogenous peptides are a smart way to utilise body's own resources to design drugs that are more specific and carry great potential to cure hard-to-treat diseases. The protein and peptide therapeutics market is a multi-billion dollar market and researchers are trying their best to improve the therapy by devising strategies for their oral delivery. The report portrays efforts of various pharmaceutical companies in making the transition towards oral delivery by developing innovative technologies and testing multiple drug candidates based on these technologies. A vast amount of activity is happening in this area as seen by the myriad of discoveries, patents, collaborations and grants. Highlights: - The market is characterized by the presence of 76 molecules in different phases of development.Four molecules are in the late stage clinical trials (phase III); of these, Oral Octreolin, Ostora and Plecanatide are likely to be made commercially available in 2016. - Diabetes stands out among the indication groups for which various molecules are in investigational studies. Nearly 37% of the total molecules under research are being developed for diabetic disorders. Other prominent areas include gastric disorders andbone diseases. - The market is not dominated by the presence of a big company or a group of companies. Several start-ups have led research efforts by developing the technologies that facilitate oral formulation of proteins and peptides. - Prominent technologies include Axcess, GIPET, Peptelligence and Disulfide Rich Peptides; a number of oral proteins and peptides are based on one of these technologies. - One of the primary drivers for growth in the industry is the rising venture capital interest and available funding from other avenues. In total, over the last 10 years, we identified total investment of close to USD 0.9 billion. - The current crop of oral proteins and peptides is likely to benefit from early success of Linzess; combined, we expect it to be a multi-billion dollar market growing at an annualised rate of 30% over the coming decade. Key Topics Covered: 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. OVERVIEW AND MARKET BACKGROUND 5. DRUG PROFILES AND MARKET FORECAST 6. CASE STUDIES: LIPROTAMASE, SANDIMMUNE, DDAVP 7. TECHNOLOGY PLATFORMS 8. RECENT PARTNERSHIPS 9. VENTURE CAPITAL SUPPORT 10. SWOT ANALYSIS 11. CONCLUSION 12. APPENDIX 1: Tabulated Data 13. APPENDIX 2: List of Companies Companies Mentioned Following companies have been mentioned in the report: 30 of the 100 Companies Featured - Abbott Laboratories - AbbVie - Affilogic - AIMM Therapeutics - Alchemia - Almirall S.A. - Alnara Pharmaceuticals - Amarillo Biosciences - Anthera Pharmaceuticals - Apollo Life Sciences - Apotex - Aptalis Pharma - Arisgen - Armour - Astellas - AstraZeneca - Avaxia Biologics - Barr Pharmaceuticals - Biocon - Biodel Inc. - Bone Medical - Bristol-Myers Squibb - Cara Therapeutics - Centocor Ortho - Chiasma Pharmaceuticals - Clinigene - Cosmo Pharmaceuticals - Diabetology Ltd. - Diasome Pharma - Digestive Care Inc. Following Universities / Research Centres have been mentioned in this report: - Elan Biotechnology Research Centre, Trinity College, - Biomedical Advanced Research and Development Agency - BioScience Innovation Centre - Hadassit Medical Research - Tianjin International Joint Academy of Biomedicine - University of Southern California - National Institute of Health Following Venture Capital firms have been mentioned in this report: 30 of the 50 Plus Firms - 7 Med Health Ventures - Abingworth - Aegis Capital Corporation - Alta Biopharma Partners - ARCH Venture Partners - Ariel Southeast Angel Partners - Ascent Biomedical Ventures - Beacon Angels - Boston Harbor Angels - Cherrystone Angels - Connecticut Innovations - CT Innovations - Devon Park BioVentures - DNA Biomedical Solutions Ltd. - F2 Ventures - F3 Ventures - Foresite Capital - Fredric Price - GGV Capital - Golden Seeds - Google Ventures - Granite State Angels - Great Point Partners - Healthcare Private Equity - InCubeBioVentures - Jerusalem Global Ventures - Johnson and Johnson Development Corporation - LaunchPad Venture Group - Life Sciences Fund Amsterdam - Lilly Ventures For more information visit http://www.researchandmarkets.com/research/g3...oteins_and
JNJ: 101.21 (+0.51), ABT: 47.40 (-0.07), ANTH: 4.93 (+0.22), BMY: 61.22 (-0.23), BIOD: 1.38 (+0.01)
Update On Prospects For Drugs To Make You Live Longer: Novartis Gets Serious
Keith Williams - at Seeking Alpha - Tue Feb 17, 10:45AM CST
ABT: 47.40 (-0.07), MRK: 58.49 (+0.13), PFE: 34.66 (+0.32), GOOGL: 547.33 (+8.68), ARIA: 8.04 (+0.26), GSK: 47.72 (+0.02), GOOG: 543.87 (+7.78), NVS: 102.64 (-0.01)
Medical Coatings (Hydrophilic and Hydrophobic coatings) Market - Regional Trends & Forecast to 2019
M2 - Mon Feb 16, 6:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/nhzhtk/medical_coatings) has announced the addition of the "Medical Coatings Market by Type, Application and Geography - Regional Trends & Forecast to 2019" report to their offering. The medical coatings market was estimated around $9.1 billion in 2013, with the high share of around 70% held by North America and Europe together. The global medical coatings market by value is projected to grow at a CAGR of 6.5% from 2014 to 2019. The high growth is forecasted to be in the Asia-Pacific due to rise of medical device manufacturing in the region. Europe is estimated to have the second highest growth around 6.37% from 2014 to 2019. Advancements in medical device designing have led to improvement of existing medical devices as well as introduction of new technologies. These devices are made of metals such as stainless steel, aluminum or ceramic such as bioglass or alumina. Not all these materials are compatible when in contact with tissues and body fluids and can cause complications, for instance, infection and blood clots. Coatings help to remove these difficulties. Some coatings help to make the device biocompatible while others help to prevent microbial infections. It may also be hydrophilic or hydrophobic according to the requirement. Coatings also help to reduce static and kinetic friction between two different surfaces. Based on properties, medical coatings can be broadly classified into hydrophilic and hydrophobic coatings. However, there are other types of coatings such as antimicrobial, protective, optical, lubricious, pharmacological and so. The most commonly used chemistries in coatings are parylene, silicones, and fluoropolymers. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Medical Coatings Market, By Type 8 Medical Coatings Market, By Application 9 Regional Analysis 10 Competitive Landscape 11 Company Profiles - AST Products Inc. - Abbott Laboratories - Biocoat Inc. - Covalon Technologies Ltd. - Harland Medical Systems Inc. - Hydromer Inc. - Precision Coatings Co. Inc. - Royal DSM - Specialty Coating Systems Inc. - Surmodics Inc. For more information visit http://www.researchandmarkets.com/research/nh...l_coatings
ABT: 47.40 (-0.07)
Cardiac Marker Diagnostic Testing Markets 2015
M2 - Mon Feb 16, 5:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/n3jhj5/cardiac_marker) has announced the addition of the "Cardiac Marker Diagnostic Testing Markets" report to their offering. Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies. Highly-attractive cardiac marker areas of growth covered in this review include: the cardiac rapid assay market, troponins, Creatine kinase-myocardial band (CK-MB) and brain natriuretic peptide (BNP) testing. Also examined are heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure, cardiac panels and point of care (POC) cardiac markers. This study also provides a thorough analysis of the companies known to be marketing, manufacturing or developing cardiac marker products in the U.S. and worldwide, as well as detailed tables, charts and figures covering the U.S., Europe and Asia markets. Key Topics Covered: 1. Overview 2. The Basics of Biomarkers 3. Cardiac Marker Testing Markets: Market Segment Analysis: Size, Growth and Share 4. Cardiovascular Disease Markers 5. Cardiac Marker Testing Development Issues 6. Business Trends in the Industry 7. Important Technology Trends 8. Company Profiles - Abbott Laboratories and SWOT Analysis - Alere and SWOT Analysis - Beckman Coulter (now part of Danaher) - Biosite, Inc. (now a brand of Alere) - bioM?rieux - CardioGenics - Chek Diagnostics - diaDexus and SWOT Analysis - Health-Chem Diagnostics (HCD) - LifeSign, LLC - Ortho-Clinical Diagnostics, Inc. and SWOT Analysis - PTS Diagnostics - PreMD, Inc. - Radiometer Medical - Randox Laboratories Ltd. - Response Biomedical - Roche Diagnostics - Sanyo Chemical Industries Ltd. - Shionogi & Co., Ltd. - Siemens Healthcare Diagnostics - Sierra Resources International - Spectral Diagnostics, Inc. For more information visit http://www.researchandmarkets.com/research/n3...iac_marker
ABT: 47.40 (-0.07), DHR: 87.22 (+0.18)
Enzymotec elects Holger Liepmann to board
M2 - Mon Feb 16, 3:21AM CST
Bio-active lipid company Enzymotec (NasdaqGS:ENZY) revealed on Friday that Holger Liepmann has joined its board of directors, effective 12 February 2015.
ABT: 47.40 (-0.07), ENZY: 8.29 (+0.45)
Marijuana Firms Should Not Invest Scarce Economic Resources In U.S. Farmland
Anthony Cataldo - at Seeking Alpha - Sun Feb 15, 6:58AM CST
KO: 42.05 (-0.08), ABT: 47.40 (-0.07), PFE: 34.66 (+0.32), LLY: 70.36 (-0.54), KRFT: 63.97 (-0.11), BMY: 61.22 (-0.23), JNJ: 101.21 (+0.51), MRK: 58.49 (+0.13), PPC: 27.05 (-0.50), PE: 16.25 (+0.34), CPB: 47.17 (-0.05), GIS: 53.54 (+0.12)
SmarTrend Watching for Potential Pullback in Shares of Abbott Laboratories After 1.92% Gain
Comtex SmarTrend(R) - Fri Feb 13, 3:54PM CST
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $45.02 to a high of $46.17. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $45.25 on volume of 6.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 47.40 (-0.07)
3 Health Care Stocks On The Rise
at The Street - Fri Feb 13, 11:04AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
ABT: 47.40 (-0.07), ALXN: 184.90 (+2.61), ABBV: 60.62 (-0.25)
$173 Billion Wearable Technology Market Report 2015-2020 - Analysis of 221 Companies Offering 132 Different Wearable Technology Products
M2 - Thu Feb 12, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/pwzm38/wearable) has announced the addition of the "Wearable Technology: 2015" report to their offering. Wearable technology will be worth USD 22.7 billion in 2015 rising to USD 173.3 billion by 2020, but the long-term potential of the sector will make these numbers seem rather small. The wearable technology market currently contains the following product segments: body sensors, smart watches, smart glasses, personal video recorders, electronic apparel and jewellery. These products are being used for the following purposes: health and activity tracking, sports performance monitors, wearable web, healthcare, life logging, location tracking and fashion and protective apparel. All these segments are included in this report. The report includes forecasts from 2014 to 2020 for smart watches, smart glasses, fitness and activity trackers and sports performance monitors. You will find very clear and detailed explanations of these and a wide range of other segments of the wearable technology market - plus plenty of examples of companies and products that occupy each of these segments. This report also contains a detailed review and status report for the main enabling technologies that will take the wearables market to the next level: ECG, body power, multi-function earbuds, thought control, electronic contact lenses and bio sensors (ingestibles and implants). You will also be able to read a very clear and detailed analysis of the future direction of the wearable technology market which will see the sector evolve from a largely device-focused industry into something far larger and more exciting. Key Topics Covered: 1. Executive Summary 2. Introduction: Market Segmentation 3. Market Developments: Last 12 Months 4. Wearable Technology Company Profiles 5. Future: Important Enabling Technologies 6. Market Analysis 7. Two $1 Trillion Wearables Opportunities 8. Market Forecasts Companies Mentioned - Abbott Laboratories - Adidas - Apple Watch - Casio - Ezio - FiLIP Technologies - Fitbit - Fitbug - Garmin - Google - Huawei B1 TalkBand - Intel - Jawbone - LG - Lenovo - Medtronic - Microsoft - Misfit Wearables - Motorola Mobility - Nike - Nissan - Omega Wave - Pebble - Pivothead - Polar - Qualcomm - Samsung - Sony - TomTom For more information visit http://www.researchandmarkets.com/research/pwzm38/wearable
ABT: 47.40 (-0.07), MDT: 78.63 (-0.39), QCOM: 71.68 (+0.31), GRMN: 49.45 (-0.15)
AAC Holdings beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 3:31PM CST
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Expands De Novo Pipeline with Hospital Entry in Southern California
Business Wire - Tue Feb 03, 5:45AM CST
AAC Holdings, Inc. (NYSE: AAC), added to its pipeline of de novo growth opportunities with the entry into a definitive agreement for the acquisition, through its subsidiary, Behavioral Healthcare Realty, LLC, of an 84-licensed-bed hospital in Aliso Viejo, California for an aggregate of $13.5 million in cash. The closing is expected to occur during the first quarter of 2015 and is subject to certain closing conditions, including the amendment or removal of certain use restrictions on the property.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Schedules Fourth Quarter 2014 Earnings Release and Conference Call Dates
Business Wire - Mon Jan 26, 3:19PM CST
AAC Holdings, Inc. (NYSE: AAC) announced details for the release of its results for the fourth quarter and year ended December 31, 2014.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Takes Next Step to Expand Outpatient Treatment Strategy with Execution of Definitive Acquisition Agreement in Rhode Island
Business Wire - Mon Jan 26, 5:45AM CST
AAC Holdings, Inc. (NYSE: AAC), through its subsidiary AAC Rhode Island Acquisition Sub, LLC, has signed a definitive agreement to acquire Clinical Services of Rhode Island, Inc. ("CSRI"
, a provider of intensive outpatient substance abuse treatment services, for $665,000 in cash and $1,335,000 worth of restricted shares of AAC Holdings' common stock. The acquisition, which is subject to certain closing conditions such as the assignment of certain contracts and the receipt of certain licenses necessary to operate the business, is expected to close during the second quarter of 2015. AAC: 37.33 (+4.07)
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
BOFI: 89.96 (-0.66), BGMD: 0.70 (-0.08), AUO: 5.34 (+0.07), AAC: 37.33 (+4.07), AAPL: 128.79 (-3.38)
AAC Holdings, Inc. Provides Facility Updates in California, Florida and Nevada
Business Wire - Tue Jan 20, 5:45AM CST
AAC Holdings, Inc. (NYSE: AAC), disclosed that on January 8, 2015, its new substance abuse outpatient center in Las Vegas, Nevada, received full licensure for intensive outpatient treatment services and has begun treating patients at the facility.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Plans for Growth with Lease Signing for New Headquarters
Business Wire - Mon Jan 12, 2:16PM CST
AAC Holdings, Inc. (NYSE: AAC), announced plans to support its next stage of growth with the signing by its wholly owned subsidiary American Addiction Centers, Inc. of a 102,000-square-foot, 10-year lease at 200 Powell Place in Brentwood, Tennessee for its new corporate headquarters and call center. The Company expects to begin transitioning from its current space in the third quarter of 2015 with a completed move anticipated by late third quarter 2015.
AAC: 37.33 (+4.07)
Quest Diagnostics Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 12:40PM CST
Last month, Quest Diagnostics' (DGX) Simplexa Flu A/B & RSV Direct Kit won U.S. Food & Drug Administration (FDA) clearance for testing eight additional influenza viruses.
PMC: 24.25 (+0.32), AFAM: 31.15 (+1.56), AAC: 37.33 (+4.07), DGX: 71.29 (+0.67)
AAC Holdings, Inc. Executes Growth Strategy with Agreement to Acquire In-Network Substance Abuse Treatment Provider in Florida for $13 Million
Business Wire - Mon Dec 15, 3:01PM CST
American Addiction Centers, Inc., a subsidiary of AAC Holdings, Inc. (NYSE: AAC), has signed a definitive agreement to acquire Recovery First, Inc., a Florida-based provider of substance abuse treatment and rehabilitation services, for $13 million in cash. The acquisition, which is subject to certain closing conditions such as the assignment of certain contracts and the receipt of certain licenses necessary to operate the business, is expected to close during the first quarter of 2015.
AAC: 37.33 (+4.07)
Is AAC Holdings (AAC) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 7:42AM CST
One stock that might be an intriguing choice for investors right now is AAC Holdings as this security in the Specialized Health Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
AAC: 37.33 (+4.07)
Surging Earnings Estimates Signal Good News for AAC Holdings (AAC) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:31AM CST
AAC Holdings (AAC) sees solid earnings estimate revisions, and the stock is showing decent short-term momentum as well, rising nearly 45% in the past month.
AAC: 37.33 (+4.07)
AAC Holdings EPS of $0.14
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:55PM CST
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Reports Third Quarter 2014 Results
Business Wire - Wed Nov 05, 4:18PM CST
AAC Holdings, Inc. (NYSE: AAC), the parent holding company of American Addiction Centers, Inc., announced its results for the third quarter ended September 30, 2014. All comparisons included in this release are for the third quarter of 2014 to the third quarter of 2013 unless otherwise noted.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call Dates
Business Wire - Tue Oct 28, 9:21AM CDT
AAC Holdings, Inc. (NYSE: AAC), the parent holding company of American Addiction Centers, Inc., announced details for the release of its results for the third quarter ended September 30, 2014.
AAC: 37.33 (+4.07)
AAC Holdings, Inc. Announces Closing of Initial Public Offering
Business Wire - Tue Oct 07, 3:01PM CDT
AAC Holdings, Inc. (NYSE: AAC) (the "Company"
, the parent holding company of American Addiction Centers, Inc., announced today the closing of its initial public offering of 5,750,000 shares of its common stock at a public offering price of $15.00 per share, which includes the exercise in full of the underwriters' over-allotment option to purchase an additional 250,000 shares from the Company and 500,000 shares from certain selling stockholders. The Company estimates net proceeds from the offering to be approximately $69.1 million after deducting underwriting discounts and commissions and estimated offering expenses. AAC: 37.33 (+4.07)
Online Retailer Wayfair Leads List Of 6 IPOs Thursday
at Investor's Business Daily - Thu Oct 02, 3:02PM CDT
Online retailer Wayfair popped 32% in its stock market debut Thursday, leading a list of six IPOs. Wayfair (W) raised $319 million by offering 11 million shares at 29, above its expected range of 25 to 28. The stock was above 38 in late-afternoon...
ATTO: 12.01 (+0.25), W: 23.67 (-0.45), FMSA: 6.60 (-0.01), VWR: 25.67 (-0.28), AAC: 37.33 (+4.07), CALA: 16.03 (+0.31), YDLE: 12.82 (-0.19), JPEP: 14.94 (-0.12)
AAC Holdings, Inc. Announces Pricing of Initial Public Offering
Business Wire - Wed Oct 01, 6:04PM CDT
AAC Holdings, Inc. (NYSE: AAC) (the "Company"
, the parent holding company of American Addiction Centers, Inc., announced today the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $15.00 per share, for a total of approximately $65.6 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. In connection with the offering, the Company and certain selling stockholders have granted the underwriters a 30-day over-allotment option to purchase up to an additional 750,000 shares of common stock. The shares are expected to begin trading tomorrow, October 2, 2014, on the New York Stock Exchange under the symbol "AAC." The offering is expected to close on October 7, 2014. AAC: 37.33 (+4.07)
Solar Power, Biotechs Among 11 IPOs Planned This Week
at Investor's Business Daily - Mon Sep 29, 6:24PM CDT
The IPO market is maintaining a brisk pace with 11 scheduled this week, including a solar power company, three tech firms and three biotech companies. Vivint Solar (VSLR), a competitor to the Elon Musk-backed SolarCity (SCTY), plans to raise $350...
ATTO: 12.01 (+0.25), VWR: 25.67 (-0.28), JMEI: 13.30 (+0.07), ZEN: 24.42 (+0.30), VSLR: 8.08 (+0.02), JPEP: 14.94 (-0.12), W: 23.67 (-0.45), FMSA: 6.60 (-0.01), SCTY: 52.28 (-0.76), DERM: 16.91 (+0.68), AAC: 37.33 (+4.07), CALA: 16.03 (+0.31), AAVL: 36.96 (+0.27), YDLE: 12.82 (-0.19), JD: 27.30 (-0.19), BABA: 86.19 (+1.50)
Applied Optoelectronics' (AAOI) CEO Thompson Lin on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - 36 mins ago
AAOI: 10.51 (+0.16)
Applied Optoelectronics posts 4Q profit
Automated Insights - Wed Feb 25, 5:24PM CST
SUGAR LAND, Texas (AP) _ Applied Optoelectronics Inc. (AAOI) on Wednesday reported fourth-quarter net income of $702,000, after reporting a loss in the same period a year earlier.
AAOI: 10.51 (+0.16)
Applied Optoelectronics beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 3:19PM CST
AAOI: 10.51 (+0.16)
Applied Optoelectronics to Announce Fourth Quarter and Year 2014 Financial Results on February 25, 2015
GlobeNewswire - Mon Jan 26, 3:03PM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced that it will release financial results for its fourth quarter and year ended December 31, 2014 after U.S. markets close on Wednesday, February 25, 2015.
AAOI: 10.51 (+0.16)
Applied Optoelectronics Reports Preliminary Fourth Quarter 2014 Revenue
GlobeNewswire - Tue Jan 13, 3:03PM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced preliminary revenue for the fourth quarter ended December 31, 2014.
AAOI: 10.51 (+0.16)
Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
ARCX: 19.48 (-0.28), AAOI: 10.51 (+0.16), BEAV: 63.72 (-0.49), BBRG: 13.68 (+0.33), BCOR: 14.27 (+0.21)
Applied Optoelectronics Completes Taiwan Factory Move
GlobeNewswire - Tue Dec 02, 7:30AM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced the completion of the move to a new, larger factory in New Taipei City, Taiwan.
AAOI: 10.51 (+0.16)
Applied Optoelectronics, Inc. Ranked Number 374 Among the Fastest Growing Companies in North America on Deloitte's 2014 Technology Fast 500(TM)
GlobeNewswire - Thu Nov 13, 10:58AM CST
Applied Optoelectronics, Inc. (Nasdaq:AAOI) today announced it ranked No. 374 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. The ranking was based on Applied Optoelectronics' 214% revenue growth from 2009 to 2013.
AAOI: 10.51 (+0.16)
Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST
FSM: 4.39 (+0.10), HEAR: 2.57 (+0.02), JRJC: 5.85 (+0.23), CVO: 2.14 (+0.24), AAOI: 10.51 (+0.16), UNIS: 4.09 (+0.12), HIIQ: 7.13 (-0.03), CYAN: 8.16 (-0.02), PTX: 10.34 (+0.79), TRMR: 2.43 (+0.01), PRKR: 0.98 (-0.05), SUMR: 2.78 (-0.07), VSLR: 8.08 (+0.02), RVP: 4.22 (+0.01), ASCMA: 44.86 (+0.31), ICUI: 88.15 (-0.18), CALL: 7.49 (-0.14), DMD: 4.96 (+0.04), AST: 3.94 (-0.02), ASEI: 52.10 (-0.54)
Applied Optoelectronics (AAOI) Stock Lower After Earnings Miss
at The Street - Tue Nov 11, 9:55AM CST
Applied Optoelectronics (AAOI) is falling Tuesday after missing analysts' estimates for earnings in the third quarter
AAOI: 10.51 (+0.16)
Applied Optoelectronics misses by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:37PM CST
AAOI: 10.51 (+0.16)
Applied Optoelectronics Reports Sixth Consecutive Quarter of Record Revenue
GlobeNewswire - Mon Nov 10, 3:10PM CST
Third Quarter 2014 Highlights
AAOI: 10.51 (+0.16)
Infinera Stock Pops After Q3 Beat, Raised Outlook
at Investor's Business Daily - Thu Oct 23, 11:25AM CDT
Infinera stock soared to a more than six-year high Thursday after the fiber-optics parts maker posted Q3 earnings late Wednesday that blew past estimates and raised its Q4 guidance. Sunnyvale, Calif.-based Infinera (INFN) saw its stock rise 25% in...
FNSR: 20.79 (-0.05), AAOI: 10.51 (+0.16), JDSU: 13.39 (-0.12), CIEN: 20.79 (+0.40), INFN: 17.33 (-0.05)
iRobot Beats on Q3 Earnings, Hikes 2014 EPS Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 1:30PM CDT
iRobot Corporation (IRBT) reported strong earnings and improved year over year revenues for the third quarter of 2014.
AAOI: 10.51 (+0.16), AA: 15.00 (-0.74), IRBT: 32.39 (+0.35), AAPL: 128.79 (-3.38)
The Zacks Analyst Blog Highlights:iRobot, Alcoa, Applied Optoelectronics and Apple
PR Newswire - Wed Oct 22, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iRobot Corporation (Nasdaq:IRBT-Free Report), Alcoa Inc. (NYSE:AA-Free Report), Applied Optoelectronics, Inc. (Nasdaq:AAOI-Free Report) and Apple Inc. (Nasdaq:AAPL-Free Report).
AAOI: 10.51 (+0.16), AA: 15.00 (-0.74)
iRobot to Ride Growth Trajectory on New Contracts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:52PM CDT
Premier robot manufacturing company iRobot Corporation (IRBT) announced the receipt of a new contract from the Naval Surface Warfare Center, Indian Head Explosive Ordnance Disposal Technology Division.
AAOI: 10.51 (+0.16), AA: 15.00 (-0.74), IRBT: 32.39 (+0.35), AAPL: 128.79 (-3.38)
Applied Optoelectronics, Inc. (AAOI) in Focus: Stock Soars 10.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:18AM CDT
Applied Optoelectronics, Inc. (AAOI) was a big mover last session, as the company saw its shares rise by above 10% on the day.
AMKR: 9.24 (-0.18), AMBA: 56.64 (-1.06), AAOI: 10.51 (+0.16), RMBS: 12.07 (-0.05)
Applied Optoelectronics to Announce Third Quarter 2014 Financial Results on November 10, 2014
GlobeNewswire - Tue Oct 07, 3:03PM CDT
Applied Optoelectronics, Inc. (Nasdaq:AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet data center, and fiber-to-the-home markets, today announced that it will release financial results for its third quarter ended September 30, 2014 after U.S. markets close on Monday, November 10, 2014.
AAOI: 10.51 (+0.16)
These 5 Big Caps Hit New Closing Highs
at Investor's Business Daily - Wed Feb 25, 7:02AM CST
A handful of big companies made big moves Tuesday as several Apple (AAPL) chip suppliers and two pharmaceutical distributors hit new closing highs. Today's Screen of the Day features Big Cap Leaders, generally top stocks with market values of at...
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), SWKS: 87.73 (-0.45), CAH: 88.30 (-0.95), TSM: 25.04 (unch), AAPL: 128.79 (-3.38), AVGO: 112.68 (-0.50)
Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 8:30AM CST
Pharmacy benefit manager Express Scripts Holding Company posted fourth-quarter 2014 earnings per share (excluding special items) of $1.39, beating the Zacks Consensus Estimate by a penny.
ABC: 103.29 (+0.32), ESRX: 85.09 (-2.53), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95)
AmerisourceBergen completes takeover of MWI Vet Supply
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 7:33AM CST
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 5:14PM CST
Following a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel, the CMS has approved a pass-through payment for CR Bard Inc.'s (BCR) Lutonix DCB.
HYH: 46.75 (-0.76), BSX: 16.92 (+0.30), ABC: 103.29 (+0.32), BCR: 171.62 (-2.86)
LabCorp Hits New 52-Week High on Strong Q4, Covance Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 8:42AM CST
On Feb 19, 2015, LabCorp (LH) finally completed the gigantic $5.7 billion acquisition of drug development major Covance Inc.
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95), LH: 122.40 (+0.19)
LabCorp Beats Q4 Earnings, Positive on Covance Addition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 20, 9:27AM CST
Laboratory Corporation of America Holdings (LH) reported a solid fourth-quarter 2014 with adjusted earnings per share (EPS) of $1.65, up 2.5% from the year-ago quarter.
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95), LH: 122.40 (+0.19)
AmerisourceBergen Up 51.2% Since SmarTrend Uptrend Call (ABC)
Comtex SmarTrend(R) - Thu Feb 19, 9:35AM CST
SmarTrend identified an Uptrend for AmerisourceBergen (NYSE:ABC) on May 12th, 2014 at $66.30. In approximately 9 months, AmerisourceBergen has returned 51.21% as of today's recent price of $100.25.
ABC: 103.29 (+0.32)
AmerisourceBergen prices USD1,000m senior notes
M2 - Wed Feb 18, 6:09AM CST
Pharmaceutical company AmerisourceBergen (NYSE:ABC) said on Tuesday that it has priced USD500m aggregate principal amount of its 3.25% Senior Notes due 1 March 2025 and USD500m aggregate principal amount of its 4.25% Senior Notes due 1 March 2045 (collectively, the "Notes"
, in an underwritten registered public offering. ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
Vascular Solutions Set to Join the S&P SmallCap 600
PR Newswire - Tue Feb 17, 4:55PM CST
Vascular Solutions Inc. (NASD: VASC) will replace MWI Veterinary Supply Inc. (NASD: MWIV) in the S&P SmallCap 600 after the close of trading on Monday, February 23. S&P 500 constituent AmerisourceBergen Corp. (NYSE: ABC) is acquiring MWI Veterinary Supply in a transaction expected to be completed soon.
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10), VASC: 28.81 (-0.14), MHFI: 103.68 (-0.33)
AmerisourceBergen prices $1B debt offering
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 2:47PM CST
ABC: 103.29 (+0.32)
AmerisourceBergen Prices $500 Million 3.25% Senior Notes Due 2025 and $500 Million 4.25% Senior Notes Due 2045
Business Wire - Tue Feb 17, 2:37PM CST
AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 3.25% Senior Notes due March 1, 2025 and $500 million aggregate principal amount of its 4.25% Senior Notes due March 1, 2045 (collectively, the "Notes"
, in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC" on November 27, 2012. The offering is expected to close on February 20, 2015, subject to customary closing conditions. AmerisourceBergen intends to use the net proceeds from the offering, together with the net proceeds from the recently announced $1 billion senior unsecured term loan credit facility and cash on hand, to finance the previously disclosed proposed acquisition (the "Acquisition" of MWI Veterinary Supply, Inc. ("MWI" , and to pay related fees and expenses, including the retirement of all outstanding indebtedness of MWI. The offering is not contingent on the consummation of the Acquisition which, if completed, will occur subsequent to the closing of the offering. In the event that the Acquisition is not completed on or before May 15, 2015, or, if prior to such time, the acquisition agreement is terminated, other than in connection with the consummation of the Acquisition, and is not otherwise amended or replaced, then the Notes are subject to mandatory redemption, in whole but not in part, at a redemption price equal to 101% of the aggregate principal amount of the Notes, plus accrued and unpaid interest to, but not including, the redemption date. The Notes offering is expected to close prior to the consummation of the Acquisition. ABC: 103.29 (+0.32), WFC: 55.33 (-0.04)
Fitch Affirms AmerisourceBergen's Ratings at 'A-'; Outlook Negative
Business Wire - Tue Feb 17, 1:24PM CST
Fitch Ratings has affirmed the ratings for AmerisourceBergen Corp. (NYSE: ABC), including the Long-term Issuer Default Rating (IDR) at 'A-'. The ratings have been removed form Negative Watch. The Rating Outlook is Negative.
ABC: 103.29 (+0.32)
MWI Veterinary: Benefits of Takeover by AmerisourceBergen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 3:58PM CST
On Feb 11, 2015, we issued an updated research report on MWI Veterinary Supply Inc. (MWIV).
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10), CAH: 88.30 (-0.95), LH: 122.40 (+0.19)
Uptrend Call Working As AmerisourceBergen Stock Rises 48.6% (ABC)
Comtex SmarTrend(R) - Thu Feb 12, 9:11AM CST
SmarTrend identified an Uptrend for AmerisourceBergen (NYSE:ABC) on May 12th, 2014 at $66.29. In approximately 9 months, AmerisourceBergen has returned 48.59% as of today's recent price of $98.51.
ABC: 103.29 (+0.32)
Henry Schein (HSIC) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:48AM CST
We are impressed with Henry Schein's (HSIC) fourth-quarter 2014 financial results which modestly beat the Zacks Consensus Estimate for EPS, while being in line with the same for revenues.
HYH: 46.75 (-0.76), ABC: 103.29 (+0.32), BRLI: 35.05 (+0.47), HSIC: 141.01 (-0.38)
AmerisourceBergen's World Courier Expands Global Presence with New Distribution Facility in Melbourne, Australia
PR Newswire - Wed Feb 11, 1:00PM CST
World Courier, the global leader in specialty logistics and an AmerisourceBergen company, has opened the doors to its new distribution facility in Melbourne, Australia. This is the first facility in AmerisourceBergen's global network to be purpose-built to support clinical trial logistics and commercial third-party logistics (3PL). In conjunction with World Courier's specialty logistics and transportation offerings, the facility provides a complete portfolio of supply chain solutions for pharmaceutical manufacturer partners.
ABC: 103.29 (+0.32)
Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:54AM CST
Charles River Laboratories (CRL) reported fourth-quarter 2014 earnings (excluding special items) of 81 cents per share, easily beating both the Zacks Consensus Estimate of 71 cents.
BIIB: 408.94 (+4.05), ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CRL: 76.80 (+0.50)
AmerisourceBergen Announces Expiration of the Hart-Scott-Rodino Waiting Period for AmerisourceBergen's Proposed Acquisition of MWI Veterinary Supply, Inc.
Business Wire - Wed Feb 11, 6:30AM CST
AmerisourceBergen Corporation (NYSE:ABC) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its tender offer to purchase all outstanding shares of MWI Veterinary Supply, Inc. (NASDAQ: MWIV) has expired.
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
Health Care Providers and Services Equities Technical Momentum -- Cardinal Health, AmerisourceBergen, Community Health Systems, Select Medical Holdings, and McKesson
PR Newswire - Tue Feb 10, 7:35AM CST
Editor Note: For more information about this release, please scroll to bottom.
ABC: 103.29 (+0.32), MCK: 229.60 (-0.60), CAH: 88.30 (-0.95), CYH: 47.70 (-0.28), SEM: 12.82 (+0.50)
Why In The World Would AmerisourceBergen Acquire MWI Veterinary?
Rochelle Jenks - at Seeking Alpha - Tue Feb 10, 5:45AM CST
ABC: 103.29 (+0.32), MWIV: 190.00 (+0.10)
ABM Industries Up 13.0% Since SmarTrend Uptrend Call (ABM)
Comtex SmarTrend(R) - Thu Feb 19, 9:32AM CST
SmarTrend identified an Uptrend for ABM Industries (NYSE:ABM) on October 29th, 2014 at $27.14. In approximately 4 months, ABM Industries has returned 12.95% as of today's recent price of $30.65.
ABM: 30.73 (-0.39)
ABM to Present at Baird's 2015 Business Solutions Conference
GlobeNewswire - Tue Feb 17, 11:23AM CST
ABM (NYSE:ABM), a leading provider of facility solutions, today announced that Scott Salmirs, executive vice president, James Lusk, executive vice president, and David Farwell, senior vice president, will be presenting at the Baird Business Solutions Conference on Tuesday, February 24, 2015. The presentation will be held at The Pierre Hotel located in New York, New York and will begin at 3:35 p.m. ET.
ABM: 30.73 (-0.39)
The Hidden Risk Of High Dividend Growth Stocks
Kurtis Hemmerling - at Seeking Alpha - Mon Feb 16, 5:08AM CST
BDX: 148.11 (-0.59), ADP: 89.07 (-0.19), ADM: 48.10 (-0.55), ATO: 53.15 (-0.18), APD: 157.05 (+0.07), ABM: 30.73 (-0.39)
Can VASCO (VDSI) Keep its Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 10:00AM CST
VASCO Data Security International Inc. (VDSI) is set to report its fourth-quarter 2014 results before the opening bell on Feb 17.
VDSI: 25.42 (-0.87), KR: 72.35 (-0.57), ABM: 30.73 (-0.39), TV: 33.60 (-0.22)
ABM to Reduce West Boylston, MA Energy and Operating Costs by More Than $4.1 Million
GlobeNewswire - Thu Feb 12, 6:07PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, announces that this month its ABM Building Solutions business will complete a multi-million dollar contract of extensive energy and facility improvements to government and school buildings throughout the Town of West Boylston in Massachusetts. ABM's Bundled Energy Solutions program guarantees that the project will save the Town of West Boylston at least $4.1 million in energy and operating costs over the next 15 years.
ABM: 30.73 (-0.39)
ABM Awarded Integrated Facility Solutions Contract by Harley-Davidson
GlobeNewswire - Tue Feb 10, 4:00PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, has been awarded a multi-phased, integrated facility solutions contract by Harley-Davidson Motor Company.
ABM: 30.73 (-0.39)
5 Reasons To Take A Look At Telkonet
Joe Springer - Seeking Alpha - Mon Feb 02, 4:19PM CST
Telkonet (OTCQB: TKOI ) is an intelligent automation company that provides networked services for large commercial and residential buildings and facilities. Its services provide energy and operational savings as well as added value for its customers....
HON: 104.39 (+0.09), ENOC: 18.88 (+0.88), NMRX: 11.14 (-0.20), JCI: 51.34 (+0.55), CTRL: 12.75 (-0.26), ABM: 30.73 (-0.39)
Can Vulcan Materials (VMC) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 1:10PM CST
Vulcan Materials Company (VMC) is set to report fourth-quarter fiscal 2014 results on Feb 5, before the market opens.
TPH: 15.91 (+0.04), VMC: 82.38 (+1.65), SERV: 32.88 (+0.63), ABM: 30.73 (-0.39)
Can Jacobs (JEC) Deliver Yet Another Earnings Beat in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 4:05PM CST
Jacobs Engineering Group Inc. (JEC) is scheduled to report first-quarter fiscal 2015 results after the opening bell on Jan 28, 2015.
JEC: 44.75 (+0.24), GPN: 92.13 (+0.21), WNS: 23.87 (+0.58), ABM: 30.73 (-0.39)
Is ABM Industries (ABM) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 7:52AM CST
ABM Industries in the Building-Maintenance and Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
ABM: 30.73 (-0.39)
ABM Industries Appoints New Chief Executive Officer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 9:40AM CST
ABM Industries Incorporated (ABM), recently announced the appointment of Scott Salmirs as its Chief Executive Officer (CEO).
CBZ: 9.02 (+0.10), SERV: 32.88 (+0.63), ROL: 33.63 (-0.30), ABM: 30.73 (-0.39)
ABM appoints Scott Salmirs as CEO
M2 - Tue Jan 13, 3:59AM CST
ABM (NYSE:ABM), a provider of facility solutions, disclosed on Tuesday that its board of directors elected executive vice president (EVP) Scott Salmirs as successor to current president and chief executive officer (CEO) Henrik Slipsager, as of 31 March 2015.
ABM: 30.73 (-0.39)
ABM Names Industry Veteran Scott Salmirs as Next CEO
Business Wire - Mon Jan 12, 3:01PM CST
ABM (NYSE:ABM), a leading provider of facility solutions, today announced that its board of directors has named executive vice president Scott Salmirs to succeed current president and chief executive officer Henrik Slipsager, effective March 31, 2015. The board and Slipsager together determined that because of the company's recent strong performance, its depth of talent, and the completion of its reorganization and re-branding, it is the appropriate time to effect a leadership transition as a part of the board's succession planning.
ABM: 30.73 (-0.39)
ABM Granted Reversal of $94 Million Class Action Verdict - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 9:10AM CST
The California Court of Appeal recently repealed a $94 million verdict related to a wage-and-hour class action against ABM Industries (ABM).
SERV: 32.88 (+0.63), IT: 84.36 (-0.41), ROL: 33.63 (-0.30), ABM: 30.73 (-0.39)
ABM Industries meets 4Q profit forecasts
Automated Insights - Mon Jan 05, 1:46PM CST
NEW YORK (AP) _ ABM Industries Inc. (ABM) on Monday reported fiscal fourth-quarter net income climbed by 74 percent to $27.9 million.
ABM: 30.73 (-0.39)
ABM Wins Unanimous Reversal of $94 Million Judgment
GlobeNewswire - Mon Jan 05, 12:02PM CST
On December 31, 2014, ABM Industries Incorporated (NYSE:ABM) obtained reversal of a $94 million judgment in a wage-and-hour class action that was awarded by a California trial court in 2012. The California Court of Appeal, Second District, rejected the plaintiffs' theory that the company violated wage-and-hour laws by requiring some employees to remain "on call" and carry radios during rest breaks. In reversing the trial court's erroneous grant of summary judgment for the plaintiffs, the Court of Appeal agreed with ABM that "on-call" rest breaks are permissible under California law.
ABM: 30.73 (-0.39)
4 Reasons To Be Bullish On ABM Industries
Diesel - at Seeking Alpha - Thu Jan 01, 3:41AM CST
ABM: 30.73 (-0.39)
ABM Industries Earnings Hindsight: Up 3.6% in Last 14 Days (ABM)
Comtex SmarTrend(R) - Mon Dec 22, 7:11AM CST
When ABM Industries (NYSE:ABM) reported earnings 14 days ago on December 8th, 2014, analysts, on average, expected the company to report earnings of $0.57 on sales of $1.3 billion. ABM Industries actually reported earnings of $0.52 per share on sales of $1.3 billion, missing EPS estimates by $0.05 and beating revenue estimates by $1.1 million. Shares of ABM Industries have climbed from $27.04 to $28.00, representing a gain of 3.6% since the company reported earnings 14 days ago.
ABM: 30.73 (-0.39)
The Best Small-Cap Dividend Growers: Heartland Payment Systems
Stan Stafford - at Seeking Alpha - Wed Dec 17, 4:22AM CST
HPY: 49.40 (-0.24), NSP: 50.68 (-0.06), GK: 72.05 (-0.64), HCSG: 33.49 (+0.28), VVI: 27.51 (+0.16), ABM: 30.73 (-0.39)
Facilities Management - Global Strategic Business Report
M2 - Tue Dec 16, 8:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/jj3hpx/facilities) has announced the addition of the "Facilities Management - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Facilities Management in US$ Billion. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 108 companies including many key and niche players such as: ABM Industries Incorporated - Amey Plc - Aramark Corporation - Bellrock Limited - Bilfinger Europa Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MARKET TRENDS AND DRIVERS 3. COMPETITION 4. SERVICE OVERVIEW 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD - A.Market Analysis - Current & Future Analysis - Focus on Select Regional Markets - Middle East - The Cleaning Industry of Saudi Arabia - Brazil and Mexico - Recent Industry Activity B.Market Analytics IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 108 (including Divisions/Subsidiaries 118) - The United States (25) - Europe (63) - France (2) - Germany (2) - The United Kingdom (54) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (23) - Middle East (7) For more information visit http://www.researchandmarkets.com/research/jj3hpx/facilities
ABM: 30.73 (-0.39)
Drugmaker Mylan Takes Part In Pharma Feeding Frenzy
at Investor's Business Daily - Mon Feb 23, 1:59PM CST
In a rapidly consolidating industry, you're either hunter or prey. Mylan is the former. Mylan (MYL) makes generic and branded drugs to treat illnesses of the cardiovascular and central nervous systems and other disorders. It operates two segments:...
BIIB: 408.94 (+4.05), ABT: 47.40 (-0.07), VRX: 198.00 (-4.00), ACT: 290.40 (+1.29), SLXP: 156.67 (-0.43), MYL: 56.50 (-0.72), TKMR: 19.43 (-0.30), BMY: 61.22 (-0.23), AGN: 232.48 (+0.60), SHPG: 245.10 (+7.48), NPSP: 45.97 (+0.01), TBPH: 21.05 (+0.60)
Pharma M&A: Bristol-Myers, Valeant Make Deals
at Investor's Business Daily - Mon Feb 23, 11:41AM CST
The drug industry's recent spate of deals got another shot in the arm Monday as Bristol-Myers Squibb announced plans to acquire a privately held drugmaker for up to $1.25 billion, a day after Valeant Pharmaceuticals International (VRX) said that it...
AGN: 232.48 (+0.60), BIIB: 408.94 (+4.05), ABT: 47.40 (-0.07), ACT: 290.40 (+1.29), VRX: 198.00 (-4.00), SHPG: 245.10 (+7.48), TKMR: 19.43 (-0.30), NPSP: 45.97 (+0.01), MYL: 56.50 (-0.72), BMY: 61.22 (-0.23)
Positive Ad Comm vote for Vertiflex Interspinous Spacer
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 10:04AM CST
JNJ: 101.21 (+0.51), ABT: 47.40 (-0.07), MDT: 78.63 (-0.39)
The Top Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Feb 23, 2:37AM CST
ELLI: 53.71 (-0.27), JCOM: 67.41 (+0.03), CAH: 88.30 (-0.95), CIEN: 20.79 (+0.40), AET: 99.52 (-0.65), ANAC: 43.57 (+0.65), CSL: 95.10 (+0.63), HSIC: 141.01 (-0.38), MNK: 116.15 (-1.67), CAVM: 67.21 (unch), HAS: 62.08 (+0.03), BCR: 171.62 (-2.86), MCHP: 51.35 (-0.18), MYL: 56.50 (-0.72), DEPO: 22.52 (-0.19), HRL: 58.53 (+0.76), CSX: 35.21 (-0.36), DYAX: 15.32 (-0.08), LVLT: 53.87 (-0.04), CBRL: 149.56 (+3.75), MTSI: 33.53 (-1.26), AZO: 637.12 (-0.67), KNX: 32.95 (-0.04), HAE: 44.14 (+0.03), FSL: 36.29 (unch), BDX: 148.11 (-0.59), ACT: 290.40 (+1.29), BLL: 72.16 (-0.40), NUVA: 45.50 (-2.96), CDW: 38.03 (-0.06), ADBE: 78.07 (+0.39), AFFX: 11.64 (+0.07), AGN: 232.48 (+0.60), ANTM: 146.97 (-0.31), APH: 56.85 (+0.03), INFA: 43.63 (+0.08), EXAM: 40.72 (+0.45), LII: 104.70 (-1.11), CNMD: 51.53 (+0.19), BJRI: 52.47 (-0.59), DLX: 68.20 (-0.77), ABT: 47.40 (-0.07), ENDP: 85.19 (-0.06), ABCO: 53.12 (-0.58), DIOD: 28.45 (-0.16), LEG: 45.21 (-0.09), DIS: 105.57 (+0.90), GLW: 24.60 (-0.18), MAR: 82.36 (+0.11), IMAX: 35.12 (+0.19), CNC: 61.65 (+0.29), IGV: 97.86 (+0.43), CTAS: 83.70 (+0.53), FLT: 156.94 (-0.02), CMCSA: 59.62 (+0.45), FLO: 21.54 (-0.19), CRM: 62.87 (+0.94)
The Passive DGI Portfolio: Portfolio Update #3
Financially Free Investor - at Seeking Alpha - Mon Feb 23, 1:38AM CST
DWX: 44.73 (+0.14), LMT: 204.86 (-1.76), CLX: 108.99 (-0.38), MDT: 78.63 (-0.39), MON: 124.23 (-0.71), UTX: 123.37 (-0.42), WMT: 83.57 (-1.00), O: 51.10 (+0.23), INTC: 33.94 (-0.47), PEP: 99.50 (-0.08), JNJ: 101.21 (+0.51), CDK: 46.99 (-0.37), QCOM: 71.68 (+0.31), MSFT: 43.99 (-0.10), APD: 157.05 (+0.07), ABT: 47.40 (-0.07), HCP: 42.30 (+0.14), EMR: 58.30 (-0.25), COP: 67.53 (+0.44), MO: 55.64 (-0.08), WM: 54.53 (+0.06), WBA: 80.01 (-0.38), ADP: 89.07 (-0.19), OHI: 40.86 (+0.80), MCD: 98.66 (+3.68), TEVA: 56.52 (-0.26), PG: 85.46 (-0.04), CVX: 108.58 (+0.62), AFL: 61.95 (-0.11), CL: 71.01 (unch)
Abbott Laboratories declares $0.24 dividend
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:42AM CST
ABT: 47.40 (-0.07)
Makers of pricey drugs working on new payment model
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:10AM CST
ABT: 47.40 (-0.07), BIIB: 408.94 (+4.05), BMRN: 107.50 (+1.47), PFE: 34.66 (+0.32), SGMO: 16.86 (+0.38), AMGN: 158.08 (+0.71), LLY: 70.36 (-0.54), BMY: 61.22 (-0.23), GSK: 47.72 (+0.02), CELG: 123.10 (-0.08), JNJ: 101.21 (+0.51), QURE: 21.65 (+1.20), GILD: 104.43 (-0.27), BAX: 68.86 (-0.20), MRK: 58.49 (+0.13), AZN: 69.67 (+0.35), NVS: 102.64 (-0.01)
Abbott to Present at Cowen and Company 35th Annual Health Care Conference
PR Newswire - Thu Feb 19, 8:00AM CST
Abbott (NYSE: ABT) will present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3, 2015. Scott White, senior vice president, international nutrition, and Brian Yoor, vice president, investor relations, will participate in the conference at 9 a.m. Central time.
ABT: 47.40 (-0.07)
The Best Large Cap Stocks To Buy In Portfolios
Todd Campbell - at Seeking Alpha - Thu Feb 19, 6:43AM CST
OCR: 75.20 (-1.47), CAH: 88.30 (-0.95), PSA: 198.28 (-0.22), SLG: 127.12 (+0.24), AET: 99.52 (-0.65), VTR: 74.43 (-0.11), HSIC: 141.01 (-0.38), HAS: 62.08 (+0.03), BCR: 171.62 (-2.86), OTEX: 58.73 (+0.50), MCHP: 51.35 (-0.18), MYL: 56.50 (-0.72), HRL: 58.53 (+0.76), NXPI: 84.89 (-1.02), CSX: 35.21 (-0.36), BA: 153.01 (-1.37), NVDA: 22.14 (-0.17), LVLT: 53.87 (-0.04), AZO: 637.12 (-0.67), AVB: 167.98 (-0.92), SIAL: 138.07 (-0.24), SPLK: 67.50 (+1.06), FSL: 36.29 (unch), ASH: 128.01 (+1.06), BDX: 148.11 (-0.59), ACT: 290.40 (+1.29), BLL: 72.16 (-0.40), AON: 100.45 (-0.14), CDW: 38.03 (-0.06), ADBE: 78.07 (+0.39), AGN: 232.48 (+0.60), ANTM: 146.97 (-0.31), APH: 56.85 (+0.03), V: 273.01 (+0.54), Q: 65.03 (+0.54), APD: 157.05 (+0.07), PII: 157.19 (+2.07), ENDP: 85.19 (-0.06), ABT: 47.40 (-0.07), HCN: 77.63 (+1.13), ORLY: 208.69 (+1.15), DIS: 105.57 (+0.90), GLW: 24.60 (-0.18), MAR: 82.36 (+0.11), CTAS: 83.70 (+0.53), PLL: 102.17 (-1.28), FLT: 156.94 (-0.02), CMCSA: 59.62 (+0.45), CRM: 62.87 (+0.94)
Ad Comm review approaches for Vertiflex spinal implant
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 12:54PM CST
JNJ: 101.21 (+0.51), ABT: 47.40 (-0.07), MDT: 78.63 (-0.39)
Accelerate Diagnostics - A Misleading Story Ripe For Decline
Shareholder Watchdog - Seeking Alpha - Wed Feb 18, 10:28AM CST
We ended our two-year hiatus from publishing on Seeking Alpha given a unique short opportunity that we think could decline by over 65%. Like our other reports, investors need to be very aware and cautious given the degree of risk we have identified....
ABT: 47.40 (-0.07), BDX: 148.11 (-0.59), AXDX: 19.03 (+0.66), TTOO: 16.82 (-0.11), NVS: 102.64 (-0.01), NSPH: 0.29 (unch)
Oral Proteins and Peptides Market, 2015 - 2025
M2 - Wed Feb 18, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/g33dxb/oral_proteins_and) has announced the addition of the "Oral Proteins and Peptides Market, 2015 - 2025" report to their offering. The Oral Proteins and Peptides Market (2nd edition), 2015-2025 report provides a comprehensive analysis of the current state of the market and the likely future evolution over the next ten years. Endogenous peptides are a smart way to utilise body's own resources to design drugs that are more specific and carry great potential to cure hard-to-treat diseases. The protein and peptide therapeutics market is a multi-billion dollar market and researchers are trying their best to improve the therapy by devising strategies for their oral delivery. The report portrays efforts of various pharmaceutical companies in making the transition towards oral delivery by developing innovative technologies and testing multiple drug candidates based on these technologies. A vast amount of activity is happening in this area as seen by the myriad of discoveries, patents, collaborations and grants. Highlights: - The market is characterized by the presence of 76 molecules in different phases of development.Four molecules are in the late stage clinical trials (phase III); of these, Oral Octreolin, Ostora and Plecanatide are likely to be made commercially available in 2016. - Diabetes stands out among the indication groups for which various molecules are in investigational studies. Nearly 37% of the total molecules under research are being developed for diabetic disorders. Other prominent areas include gastric disorders andbone diseases. - The market is not dominated by the presence of a big company or a group of companies. Several start-ups have led research efforts by developing the technologies that facilitate oral formulation of proteins and peptides. - Prominent technologies include Axcess, GIPET, Peptelligence and Disulfide Rich Peptides; a number of oral proteins and peptides are based on one of these technologies. - One of the primary drivers for growth in the industry is the rising venture capital interest and available funding from other avenues. In total, over the last 10 years, we identified total investment of close to USD 0.9 billion. - The current crop of oral proteins and peptides is likely to benefit from early success of Linzess; combined, we expect it to be a multi-billion dollar market growing at an annualised rate of 30% over the coming decade. Key Topics Covered: 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. OVERVIEW AND MARKET BACKGROUND 5. DRUG PROFILES AND MARKET FORECAST 6. CASE STUDIES: LIPROTAMASE, SANDIMMUNE, DDAVP 7. TECHNOLOGY PLATFORMS 8. RECENT PARTNERSHIPS 9. VENTURE CAPITAL SUPPORT 10. SWOT ANALYSIS 11. CONCLUSION 12. APPENDIX 1: Tabulated Data 13. APPENDIX 2: List of Companies Companies Mentioned Following companies have been mentioned in the report: 30 of the 100 Companies Featured - Abbott Laboratories - AbbVie - Affilogic - AIMM Therapeutics - Alchemia - Almirall S.A. - Alnara Pharmaceuticals - Amarillo Biosciences - Anthera Pharmaceuticals - Apollo Life Sciences - Apotex - Aptalis Pharma - Arisgen - Armour - Astellas - AstraZeneca - Avaxia Biologics - Barr Pharmaceuticals - Biocon - Biodel Inc. - Bone Medical - Bristol-Myers Squibb - Cara Therapeutics - Centocor Ortho - Chiasma Pharmaceuticals - Clinigene - Cosmo Pharmaceuticals - Diabetology Ltd. - Diasome Pharma - Digestive Care Inc. Following Universities / Research Centres have been mentioned in this report: - Elan Biotechnology Research Centre, Trinity College, - Biomedical Advanced Research and Development Agency - BioScience Innovation Centre - Hadassit Medical Research - Tianjin International Joint Academy of Biomedicine - University of Southern California - National Institute of Health Following Venture Capital firms have been mentioned in this report: 30 of the 50 Plus Firms - 7 Med Health Ventures - Abingworth - Aegis Capital Corporation - Alta Biopharma Partners - ARCH Venture Partners - Ariel Southeast Angel Partners - Ascent Biomedical Ventures - Beacon Angels - Boston Harbor Angels - Cherrystone Angels - Connecticut Innovations - CT Innovations - Devon Park BioVentures - DNA Biomedical Solutions Ltd. - F2 Ventures - F3 Ventures - Foresite Capital - Fredric Price - GGV Capital - Golden Seeds - Google Ventures - Granite State Angels - Great Point Partners - Healthcare Private Equity - InCubeBioVentures - Jerusalem Global Ventures - Johnson and Johnson Development Corporation - LaunchPad Venture Group - Life Sciences Fund Amsterdam - Lilly Ventures For more information visit http://www.researchandmarkets.com/research/g3...oteins_and
JNJ: 101.21 (+0.51), ABT: 47.40 (-0.07), ANTH: 4.93 (+0.22), BMY: 61.22 (-0.23), BIOD: 1.38 (+0.01)
Update On Prospects For Drugs To Make You Live Longer: Novartis Gets Serious
Keith Williams - at Seeking Alpha - Tue Feb 17, 10:45AM CST
ABT: 47.40 (-0.07), MRK: 58.49 (+0.13), PFE: 34.66 (+0.32), GOOGL: 547.33 (+8.68), ARIA: 8.04 (+0.26), GSK: 47.72 (+0.02), GOOG: 543.87 (+7.78), NVS: 102.64 (-0.01)
Medical Coatings (Hydrophilic and Hydrophobic coatings) Market - Regional Trends & Forecast to 2019
M2 - Mon Feb 16, 6:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/nhzhtk/medical_coatings) has announced the addition of the "Medical Coatings Market by Type, Application and Geography - Regional Trends & Forecast to 2019" report to their offering. The medical coatings market was estimated around $9.1 billion in 2013, with the high share of around 70% held by North America and Europe together. The global medical coatings market by value is projected to grow at a CAGR of 6.5% from 2014 to 2019. The high growth is forecasted to be in the Asia-Pacific due to rise of medical device manufacturing in the region. Europe is estimated to have the second highest growth around 6.37% from 2014 to 2019. Advancements in medical device designing have led to improvement of existing medical devices as well as introduction of new technologies. These devices are made of metals such as stainless steel, aluminum or ceramic such as bioglass or alumina. Not all these materials are compatible when in contact with tissues and body fluids and can cause complications, for instance, infection and blood clots. Coatings help to remove these difficulties. Some coatings help to make the device biocompatible while others help to prevent microbial infections. It may also be hydrophilic or hydrophobic according to the requirement. Coatings also help to reduce static and kinetic friction between two different surfaces. Based on properties, medical coatings can be broadly classified into hydrophilic and hydrophobic coatings. However, there are other types of coatings such as antimicrobial, protective, optical, lubricious, pharmacological and so. The most commonly used chemistries in coatings are parylene, silicones, and fluoropolymers. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Medical Coatings Market, By Type 8 Medical Coatings Market, By Application 9 Regional Analysis 10 Competitive Landscape 11 Company Profiles - AST Products Inc. - Abbott Laboratories - Biocoat Inc. - Covalon Technologies Ltd. - Harland Medical Systems Inc. - Hydromer Inc. - Precision Coatings Co. Inc. - Royal DSM - Specialty Coating Systems Inc. - Surmodics Inc. For more information visit http://www.researchandmarkets.com/research/nh...l_coatings
ABT: 47.40 (-0.07)
Cardiac Marker Diagnostic Testing Markets 2015
M2 - Mon Feb 16, 5:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/n3jhj5/cardiac_marker) has announced the addition of the "Cardiac Marker Diagnostic Testing Markets" report to their offering. Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies. Highly-attractive cardiac marker areas of growth covered in this review include: the cardiac rapid assay market, troponins, Creatine kinase-myocardial band (CK-MB) and brain natriuretic peptide (BNP) testing. Also examined are heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure, cardiac panels and point of care (POC) cardiac markers. This study also provides a thorough analysis of the companies known to be marketing, manufacturing or developing cardiac marker products in the U.S. and worldwide, as well as detailed tables, charts and figures covering the U.S., Europe and Asia markets. Key Topics Covered: 1. Overview 2. The Basics of Biomarkers 3. Cardiac Marker Testing Markets: Market Segment Analysis: Size, Growth and Share 4. Cardiovascular Disease Markers 5. Cardiac Marker Testing Development Issues 6. Business Trends in the Industry 7. Important Technology Trends 8. Company Profiles - Abbott Laboratories and SWOT Analysis - Alere and SWOT Analysis - Beckman Coulter (now part of Danaher) - Biosite, Inc. (now a brand of Alere) - bioM?rieux - CardioGenics - Chek Diagnostics - diaDexus and SWOT Analysis - Health-Chem Diagnostics (HCD) - LifeSign, LLC - Ortho-Clinical Diagnostics, Inc. and SWOT Analysis - PTS Diagnostics - PreMD, Inc. - Radiometer Medical - Randox Laboratories Ltd. - Response Biomedical - Roche Diagnostics - Sanyo Chemical Industries Ltd. - Shionogi & Co., Ltd. - Siemens Healthcare Diagnostics - Sierra Resources International - Spectral Diagnostics, Inc. For more information visit http://www.researchandmarkets.com/research/n3...iac_marker
ABT: 47.40 (-0.07), DHR: 87.22 (+0.18)
Enzymotec elects Holger Liepmann to board
M2 - Mon Feb 16, 3:21AM CST
Bio-active lipid company Enzymotec (NasdaqGS:ENZY) revealed on Friday that Holger Liepmann has joined its board of directors, effective 12 February 2015.
ABT: 47.40 (-0.07), ENZY: 8.29 (+0.45)
Marijuana Firms Should Not Invest Scarce Economic Resources In U.S. Farmland
Anthony Cataldo - at Seeking Alpha - Sun Feb 15, 6:58AM CST
KO: 42.05 (-0.08), ABT: 47.40 (-0.07), PFE: 34.66 (+0.32), LLY: 70.36 (-0.54), KRFT: 63.97 (-0.11), BMY: 61.22 (-0.23), JNJ: 101.21 (+0.51), MRK: 58.49 (+0.13), PPC: 27.05 (-0.50), PE: 16.25 (+0.34), CPB: 47.17 (-0.05), GIS: 53.54 (+0.12)
SmarTrend Watching for Potential Pullback in Shares of Abbott Laboratories After 1.92% Gain
Comtex SmarTrend(R) - Fri Feb 13, 3:54PM CST
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $45.02 to a high of $46.17. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $45.25 on volume of 6.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABT: 47.40 (-0.07)
3 Health Care Stocks On The Rise
at The Street - Fri Feb 13, 11:04AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
ABT: 47.40 (-0.07), ALXN: 184.90 (+2.61), ABBV: 60.62 (-0.25)
$173 Billion Wearable Technology Market Report 2015-2020 - Analysis of 221 Companies Offering 132 Different Wearable Technology Products
M2 - Thu Feb 12, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/pwzm38/wearable) has announced the addition of the "Wearable Technology: 2015" report to their offering. Wearable technology will be worth USD 22.7 billion in 2015 rising to USD 173.3 billion by 2020, but the long-term potential of the sector will make these numbers seem rather small. The wearable technology market currently contains the following product segments: body sensors, smart watches, smart glasses, personal video recorders, electronic apparel and jewellery. These products are being used for the following purposes: health and activity tracking, sports performance monitors, wearable web, healthcare, life logging, location tracking and fashion and protective apparel. All these segments are included in this report. The report includes forecasts from 2014 to 2020 for smart watches, smart glasses, fitness and activity trackers and sports performance monitors. You will find very clear and detailed explanations of these and a wide range of other segments of the wearable technology market - plus plenty of examples of companies and products that occupy each of these segments. This report also contains a detailed review and status report for the main enabling technologies that will take the wearables market to the next level: ECG, body power, multi-function earbuds, thought control, electronic contact lenses and bio sensors (ingestibles and implants). You will also be able to read a very clear and detailed analysis of the future direction of the wearable technology market which will see the sector evolve from a largely device-focused industry into something far larger and more exciting. Key Topics Covered: 1. Executive Summary 2. Introduction: Market Segmentation 3. Market Developments: Last 12 Months 4. Wearable Technology Company Profiles 5. Future: Important Enabling Technologies 6. Market Analysis 7. Two $1 Trillion Wearables Opportunities 8. Market Forecasts Companies Mentioned - Abbott Laboratories - Adidas - Apple Watch - Casio - Ezio - FiLIP Technologies - Fitbit - Fitbug - Garmin - Google - Huawei B1 TalkBand - Intel - Jawbone - LG - Lenovo - Medtronic - Microsoft - Misfit Wearables - Motorola Mobility - Nike - Nissan - Omega Wave - Pebble - Pivothead - Polar - Qualcomm - Samsung - Sony - TomTom For more information visit http://www.researchandmarkets.com/research/pwzm38/wearable
ABT: 47.40 (-0.07), MDT: 78.63 (-0.39), QCOM: 71.68 (+0.31), GRMN: 49.45 (-0.15)
(0)
(0)Scroll down for more posts ▼